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Abstract: Five-membered heterocycles bearing an
exocyclic double bond have been successfully used
as substrates in asymmetric addition and cycloaddi-
tion reactions. Ylidene-heterocycles are attractive
substrates due to their high functionalization and the
presence of an electrophilic conjugated exocyclic
double bound that can participate in nucleophilic
addition reactions as well as cycloaddition reactions,
which may be triggered by the formation of aromatic
intermediates or products in many cases. During the
last decades, catalytic methodologies have been
developed using ylidene-heterocycles as substrates in
order to synthesize useful optically active heterocy-
clic derivatives. 4-Ylidene-pyrazol-5-ones, isoxazo-
lin-5-ones, 2,3-dioxopyrrolidines, rhodanines, oxazo-
lidindiones, Erlenmeyer-Ploch azlactones and 5-
ylidene-thiazolones have been successfully used as
substrates in asymmetric reactions. This review
collects the powerful research in asymmetric addition
and cycloaddition reactions where ylidene-five-mem-
bered heterocycles have been used.
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1. Introduction
Asymmetric catalysis is one of the most powerful tools
in organic chemistry to afford desired chiral com-
pounds from simple achiral starting materials with
high efficiency.[1] This field has received growing
attention due to the high demand of enantiopure
products in the pharmaceutical and agrochemical
industry as well as in the materials chemistry area.[2] In
this context, catalytic enantioselective methods for the
formation of C  C and C  heteroatom bonds have
represented an important challenge to organic chemists
during the last decades.[3] Straightforward and useful
synthetic approaches to this goal are the asymmetric
addition of nucleophiles and cycloaddition reactions
with electron-deficient alkenes, which constitute highly
atom-economy processes. Accordingly, the develop-
ment of new methodologies based on asymmetric
conjugated addition or cycloaddition reactions has
been broadly studied.[4] Commonly, these protocols
play a pivotal role in the synthesis of natural products
or in the preparation of important building blocks to be
used in organic synthesis.
Among electrophilic double bonds, those occupying
an exocyclic position with respect to a heterocycle
result especially attractive in asymmetric catalysis
giving rise to a variety of heterocycles decorated with
a chiral chain. In many cases, these asymmetric
reactions are triggered by the formation of intermedi-
ates or products with aromatic character. Chiral hetero-
cycles have found a wide range of applications in
medicinal and pharmaceutical chemistry and they are
present in many natural products such as antibiotics,
alkaloids or DNA.[5] For that reason, the use of
heterocycles bearing exocyclic double bonds as elec-
trophiles in asymmetric reactions represent an impor-
tant approach to the synthesis of highly functionalized
chiral heterocyclic products with potential use in many
different fields.
In this review, we describe the efforts to develop
efficient and useful enantioselective methodologies
using five-membered heterocycles bearing exocyclic
double bonds as electrophiles via asymmetric catalysis.
This review identifies the ylidene-heterocycles most
commonly used in asymmetric catalysis and review the
most important reactions involving transformations on
the exocyclic double bond, which in many cases are
facilitated by re-aromatization processes (Figure 1).
2. 4-Ylidene-Pyrazol-5-Ones
Pyrazol-5-ones are five membered heterocycles that
can be found in a broad variety of bioactive
compounds.[6] Some pharmaceutical uses include neu-
roprotector activity,[7] antitumor activity,[8] antioxidant
activity[9] and anti-inflammatory activity.[10] Further-
more, agrochemical uses as antibacterials and insectici-
dals have been demonstrated.[11] Besides the biological
uses, novel materials containing the pyrazolone scaf-
fold have been developed, such as analytical
detectors[12] and dyes[13] (Figure 2).
4-Ylidene-pyrazol-5-ones have shown to be very
versatile substrates in asymmetric addition reactions
obtaining novel attractive structures.[14] The exocyclic
double bond can act as Michael acceptor, thus
generating branched pyrazoles, commonly stabilized in
the enol form of the pyrazol-5-one moiety. Further-
more, the 4-ylidene-pyrazolone scaffold contains two
potential nucleophilic sites that, after the initial
Michael addition step, can lead to fused pyrazoles or
spiropyrazol-5-ones in formal cycloaddition reactions
(Scheme 1). 3-Substituted 4-ylidene-pyrazol-5-ones
prefer the more stable exocyclic double bond with the
Z-configuration. A literature survey evidences that this
stereochemistry is not always properly represented.
Figure 1. Ylidene-heterocycles commented in this review.
Figure 2. Selected bioactive compounds containing the pyrazol-
5-one and pyrazole scaffolds.
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2.1. Organocatalytic Reactions with 4-Ylidene-Pyr-
azol-5-Ones
Most of the asymmetric reactions described with 4-
ylidene-pyrazolones use organocatalytic methods. As
shown below, enamine, N-heterocyclic carbene,
phosphine and bifunctional catalysis have allowed the
reaction of 4-ylidene-pyrazolones with a broad variety
of pro-nucleophiles.
2.1.1. Reactions via Enamine Catalysis
The first asymmetric reaction involving 4-ylidene-
pyrazolones as electrophiles was described in 2011 by
Rios et al. using enamine catalysis.[15] The authors
described the synthesis of spiropyrazolones through a
one pot tandem process involving two Michael
additions and one aldol condensation followed by
dehydration (Scheme 2). The Hayashi-Jørgensen cata-
lyst C1 and benzoic acid were selected as the optimal
catalysts to afford the desired spiropyrazolones in
moderate yields but excellent stereoselectivities. A
variety of 4-ylidene-pyrazolones having aromatic and
aliphatic substituents at the double bond as well as
different functional groups in the aromatic ring were
well supported. However, R2 was limited to methyl or
ethyl groups, as bulkier groups such as phenyl or tert-
butyl hampered the reaction. The reaction showed
applicability to a wide range of enolizable aldehydes.
Finally, enals bearing aromatic substituents gave
excellent stereoselectivities but aliphatic enals gave
rise to complex reaction mixtures (Scheme 2).
In 2013, Wang and co-workers employed 4-
arylidene-pyrazolones with enones to study the cascade
double Michael addition catalyzed by quinine-derived
amine C2 (Scheme 3).[16] Benzoic acid played a pivotal
role to obtain the spiropyrazolone-cyclohexanone
adducts in high yields and excellent stereoselectivities.
The study of the substrate scope revealed that
identically substituted enones and 4-arylidene-pyrazo-
lones (R1=R2) gave excellent diastereo- and enantiose-
lectivity regardless of the electronic and steric charac-
teristics of the substituents, although yields were
slightly lower for reactants possessing electron-rich
substituents. In contrast, the reaction with substrates
having different substituents (R1¼6 R2) was complicated
and displayed low dr values. However, when one of
these substituents was an ortho-chlorophenyl group,
the diastereoselectivity improved greatly and the
spiropyrazolones with three consecutive stereogenic
centers were obtained with excellent enantioselectivity,
except with enones substituted with aliphatic groups R2
that gave low diastereoselectivity. The authors noticed
that if quinidine amine catalyst was used instead of
C2, the opposite enantiomer of the product was
obtained with similar results.
The synthesis of similar unsymmetrical diaryl-
substituted spirocyclohexanone-pyrazolones was also
described by the group of X.-W. Wang (Scheme 4).[17]
This procedure was catalyzed by a quinidine amine
catalyst C3 and ortho-fluorobenzoic acid as co-
catalyst, and provided the opposite enantiomers to
Scheme 1. Reactivity of 4-arylidene-pyrazol-5-ones.
Scheme 2. One pot double Michael addition of aldehydes to 4-
arylidene-pyrazolones.
Scheme 3. Cascade asymmetric addition of enones to 4-
arylidene-pyrazolones.
Scheme 4. Cascade asymmetric cycloaddition of enones and 4-
arylidene-pyrazolones.
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those obtained in the previous reaction. A broad
variety of aromatic and heteroaromatic enones were
tested obtaining high to excellent yields, high diaster-
eoselectivities and excellent enantiomeric excesses.
3-Methyl-4-arylidene-pyrazolones having aromatic
substituents attached to both the N atom and the double
bond (R1 and R3=aryl) were evaluated obtaining
excellent results. Remarkably, a 3-phenyl-4-arylidene-
pyrazolone tested gave lower yield and diastereoselec-
tivity, although excellent enantioselectivity.
In 2016, Pericàs et al. described an organocatalytic
synthesis of tetrahydropyrano-pyrazoles using 4-hy-
droxydinaphthylprolinol C4 as the catalyst.[18] In this
case, the arylidene-pyrazolone reacted as a formal
heterodiene in an inverse-electron demand hetero-
Diels-Alder reaction. The hydroxyl group of the
prolinol moiety demonstrated to be essential in the
diastereo- and enantioselectivity induction (Scheme 5).
Under the optimal conditions, some 4-arylidene-
pyrazolones were evaluated obtaining the best results
with R1 being a para-substituted phenyl ring, regard-
less of its electronic characteristics. A n-propyl group
at R2 was also tolerated but a higher reaction time was
required. Aromatic enals (R3=aryl) were also eval-
uated obtaining in all cases high yields (72–88%),
diastereoselectivities (up to 8:1) and enantioselectiv-
ities (84–90%).
Tetrahydropyrano[2,3-c]pyrazoles were also synthe-
sized by Pan et al. using 4-arylidene-pyrazolones and
ketones.[19] The reaction proceeded via an asymmetric
domino Michael/hemiacetalization reaction catalyzed
by dihydroquinine-derived amine C5 and 2-
FC6H4CO2H (Scheme 6). Four equivalents of ketone
were required to obtain the desired product in good
yield, excellent diastereoselectivity and high enantio-
meric excess. Good yields and excellent diastereose-
lectivities were obtained for a number of 4-arylidene-
pyrazolones regardless of the electronic or steric
features of the substituents R1 and R2. The enantio-
meric excesses of the reaction products (ca. 80%)
could be improved to >90% with a recrystallization
process. Alkyl substituents such as iPr or cyclohexyl at
R1 were also well tolerated. Furthermore, electron-rich
and electron-poor aryl rings at R3 gave higher yields
than R3=Ph.
A broad variety of enolizable ketones and alde-
hydes, including 4,4-dimethylcyclohexanone, tetrahy-
drothiopyran-4-one and pentanal were evaluated af-
fording the corresponding cycloaddition products in
moderate yield and high stereoselectivity. However,
larger cyclic ketones such as cycloheptanone led to the
single Michael addition product with fair yield but
excellent stereoselectivity (Scheme 7).
Vinylogous 4-ylidene-pyrazolones, bearing conju-
gated exocyclic double bonds, have also been em-
ployed in asymmetric catalysis. In 2019, Han, He and
Peng developed an asymmetric formal [4+2] cyclo-
addition with enolizable aldehydes catalyzed by a
proline derivative C6, related to the Hayashi-Jørgensen
catalyst.[20] A triethylsilyl protecting group was re-
quired in the catalyst to afford the spiro compounds in
good yields and diastereomeric ratios, and excellent
enantiomeric excesses (Scheme 8). A broad range of
vinylogous 4-arylidene-pyrazolones were studied, ob-
taining the desired spirocyclohexene-pyrazolones in
high yields, good diastereoselectivities and excellent
Scheme 5. Asymmetric synthesis of tetrahydropyrano-pyrazoles
from enals and 4-arylidene-pyrazolones.
Scheme 6. Asymmetric addition of cyclohexanone to 4-aryli-
dene-pyrazolones.
Scheme 7. Asymmetric reaction of carbonyl compounds and 4-
arylidene-pyrazolones catalyzed by amine C5.
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enantiomeric excesses. Diastereoselectivity decreased
when vinylogous 4-arylidene-pyrazolones were substi-
tuted with R1 being a 2-naphthyl group or R2 different
of a phenyl group. 2-Alkyl and 2-vinyl substituted
acetaldehydes also gave good yield, diastereoselectiv-
ity and enantiomeric excess (Scheme 8). Remarkably,
the unprotected spirocyclohexene-pyrazolones (without
TMS) demonstrated anticancer effect by inducing
programmed cell death.
2.1.2. Reactions under NHC Catalysis
N-Heterocyclic carbene (NHC) catalysis is a powerful
catalytic method widely employed in reactions involv-
ing aldehydes. This kind of catalysis is very efficient
in asymmetric [4+2] annulation reactions involving 4-
ylidene-pyrazolones. The first example of such reac-
tion was described in 2013 by Ye[21] employing α-
chloroaldehydes and 4-arylidene-pyrazolones catalyzed
by Bode NHC catalyst (Scheme 9).[22]
Aliphatic and aromatic α-chloroaldehydes gave the
desired cis-dihydropyrano-pyrazolones in high yields,
with good diastereo- and enantioselectivities. With
elongated reaction times, epimerization of the cis
cycloadduct to the trans isomer was observed, which
could be avoided by reducing the base load. However,
the trans isomer was favored when arylidene-pyrazo-
lones with o-chlorophenyl or 1-naphthyl substituents
were used, probably due to the larger steric hindrance
of these groups.
The same NHC catalyst has been used by Enders in
the asymmetric [4+2] annulation of enals and vinyl-
ogous 4-arylidene-pyrazolones to give chiral spirocy-
clopentane-pyrazolones (Scheme 10).[23] Enals contain-
ing para-substituted aromatic rings gave excellent
results regardless of their electronic characteristics.
Enals bearing heteroaryl and vinyl substituents were
also tolerated. Substitution on the arylidene-pyrazo-
lones was also evaluated obtaining the best results
when R2 was a tBu group. On the other hand, aryl,
heteroaryl and vinyl substituents R1 at the side chain
were tolerated, the reaction products being obtained
with moderate yields and good stereoselectivities. The
substituent at the nitrogen atom R3 could be a
substituted phenyl or benzyl group. However, when it
was a p-chlorophenyl group, a slight decrease in the
stereoselectivity was observed (Scheme 10).
Two years later, Zhong and Yang described an
asymmetric formal [4+2] annulation between γ-
chloroenals and 4-arylidene-pyrazolones to construct
spirocyclohexane-pyrazolones.[24] The reaction was
catalyzed by the N-mesityl-substituted triazolium salt
C8 using NaOAc as base in the presence of 4 Å
molecular sieves. These conditions were applied to a
wide range of differently substituted 4-arylidene-
pirazolones obtaining in all cases moderate to high
yields, good diastereomeric ratios and enantiomeric
excesses above 99%ee. Only when R1 was a
cyclohexyl group the enantiomeric excess decreased to
90%. Furthermore, γ-chloroenals bearing aryl or
heteroaryl groups at the β position were well supported
(Scheme 11).
2.1.3. Phosphine Catalysis
Phosphine catalysis has been commonly used in cyclo-
addition reactions that involve allenes or allenoates. In
Scheme 8. Asymmetric formal [4+2] cycloaddition of alde-
hydes and vinylogous 4-arylidene-pyrazolones.
Scheme 9. Asymmetric [4+2] cycloaddition of α-chloroalde-
hydes and 4-arylidene-pyrazolones.
Scheme 10. Asymmetric cycloaddition of enals and vinylogous
4-arylidene-pyrazolones.
Scheme 11. Formal [4+2] annulation of γ-chloroenals and 4-
arylidene-pyrazolones.
REVIEWS asc.wiley-vch.de
Adv. Synth. Catal. 2021, 363, 5196–5234 © 2021 The Authors. Advanced Synthesis & Catalysis
published by Wiley-VCH GmbH
5201
Wiley VCH Dienstag, 30.11.2021
2123 / 223857 [S. 5201/5234] 1
2015, Guo and co-workers used this type of catalysis
in the reaction of allenoates and 4-arylidene-pyrazo-
lones to obtain chiral spiropyrazolones.[25] The racemic
reaction proceeded with excellent yields when MePPh2
in toluene at room temperature was used. The
asymmetric version of the reaction was achieved with
chiral phosphine C9 in toluene at   10 °C obtaining in
general fair diastereoselectivity and good enantioselec-
tivity for a number of 4-arylidene-pyrazolones having
aromatic rings attached to the double bond
(Scheme 12).
2.1.4. Bifunctional Hydrogen-Bonding/Brønsted Base
Catalysis
Bifunctional catalysis has been broadly studied in
reactions with 4-arylidene-pyrazolones, being the most
common organocatalytic method used. The first exam-
ple described in 2012 by Wang and Jiang reported an
asymmetric Michael/cyclization process using isothio-
cyanato imides as pronucleophiles (Scheme 13).[26] The
reaction was catalyzed by a rosin-derived thiourea C10
in dichloromethane achieving the spiropyrazolones in
excellent yield and high stereoselectivity. Besides
isothiocyanato imide, methyl isothiocyanato acetate
(R3=OMe) was tested giving the corresponding product
with good yield but moderate stereoselectivity.
The same group reported a similar reaction using
the same catalyst and isothiocyanato oxindoles as
pronucleophiles to give bi-spirocyclic oxindole deriva-
tives (Scheme 14).[27] Under these conditions, 4-aryli-
dene-pyrazolones having a variety of aryl or heteroaryl
groups R1 (R2=H) attached to the double bond gave
excellent results. However, when dimethyl unsaturated
pyrazolone (R1=R2=Me) was used the corresponding
product was afforded in only 11% ee. One year later,
the group of Yuan reported a quinine catalysis for the
same reaction obtaining good yields, fair diastereose-
lectivity and good enantiomeric excesses (see
Scheme 38).
In 2013, Wang and Tao developed an asymmetric
Michael/aromatization reaction of 4-arylidene-pyrazo-
lones with oxazol-5-ones catalyzed by an isosteviol-
derived thiourea C11.[28] Molecular sieves and low
temperatures favored high enantiomeric excesses.
Remarkably, the reaction occurs in a C4-regioselective
fashion regarding the oxazolone giving masked amino
acid structures containing a 3-hydroxypyrazole motif
(Scheme 15).
A broad scope regarding 4-arylidene-pyrazolones
was demonstrated and the products were obtained with
high yields, good dr (>10:1) and high enantiomeric
excesses regardless of the electronic features of the
substituent attached to the double bond. Regarding the
oxazol-5-one partner, the best results were obtained
with those with a benzyl group attached to position 4
of the heterocyclic ring (R3=Bn).
Isosteviol-derived thiourea catalyst C11 was also
used in the addition of diarylphosphine oxides to 4-
arylidene-pyrazolones described by Wang and co-
workers.[29] The reaction was first studied in a racemic
Scheme 12. Phosphine-catalyzed reaction of allenoates and 4-
arylidene-pyrazolones.
Scheme 13. Asymmetric reaction of isothiocyanato imides and
4-arylidene-pyrazolones catalyzed by bifunctional thiourea
C10.
Scheme 14. Asymmetric cycloaddition of isothiocyanato oxin-
doles and 4-arylidene-pyrazolones.
Scheme 15. Asymmetric C4-regioselective addition of oxazol-
5-ones to 4-arylidene-pyrazolones.
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fashion, the desired products being obtained in very
high yields in Et2O at room temperature in the absence
of catalyst. The asymmetric reaction was carried out at
0 °C to avoid the background reaction. The
phosphorus-containing pyrazoles were obtained with
fair to high yields and moderate enantiomeric excesses.
No significant differences were observed with sub-
strates having either electron-donating or electron-
withdrawing groups attached to the double bond. The
best results were obtained with bulky substituents such
as 2-naphthyl (Scheme 16).
In 2014, the group of Xie developed the synthesis
of chiral spirocyclohexane-pyrazolones through a one-
pot sequential Michael/Michael/Aldol reaction of 1,3-
dicarbonyl compounds with ylidene-pyrazolones and
α,β-unsaturated aldehydes (Scheme 17).[30] The reac-
tion was sequentially catalyzed by a Cinchona alkaloid
thiourea C12 and piperidine, providing the spirocyclic
compounds with high yield and stereoselectivity for a
number of pyrazolones and aldehydes. A notable
feature of this reaction is the formation of up to six
consecutive stereogenic centers, one of them being
quaternary and five tertiary.
Since 2014, a number of organocatalytic procedures
for the synthesis of dihydropyrano[2,3-c]pyrazoles
from malononitrile and 4-arylidene-pyrazolones
through a cascade Michael addition/cyclization have
been developed. A bifunctional diaminocyclohexane-
thiourea catalyst C13 was employed by Zhao to furnish
the reaction products with excellent yields and fair to
good enantiomeric excesses (Scheme 18,A).[31] In this
example, 3-trifluoromethyl-4-arylidene-pyrazolones
bearing aromatic groups attached to the nitrogen and
the double bond were used as electrophiles. In 2015,
Du and co-workers used a quinine-derived squaramide
C14 as catalyst. The reaction was tested with 3-
methyl-, 3-phenyl- and 3-trifluoromethyl- arylidene-
pyrazolones having different aromatic groups attached
to the double bond and the heterocyclic N atom.[32] The
reaction products were obtained in excellent yields but
only fair enantiomeric excesses (Scheme 18,B). Fi-
nally, a squaramide derived from (1R,2R)-1,2-diphe-
nylethane-1,2-diamine C15 was used by Zhou as
catalyst.[33] With this catalyst both the yield and the
enantiomeric excesses were excellent for a number of
substrates bearing aromatic and heteroaromatic groups
at the double bond (Scheme 18,C).
An organocatalyzed cascade aza-Michael/Michael
addition of 2-tosylamino enones and 4-arylidene-
pyrazol-5-ones has been described by Du.[34] The
reaction, catalyzed by a quinidine-derived squaramide
C16, led to highly functionalized spiropyrazolone-
tetrahydroquinolines in excellent yields, excellent
diastereomeric ratios and good enantiomeric excesses
(Scheme 19).
Later, the same group described another aza-
Michael/Michael reaction with N-tosyl-aminomethyl
enones to obtain chiral spiropyrrolidine-pyrazolones.[35]
The reaction was catalyzed by a 1,2-diaminocyclohex-
ane-derived squaramide C17 obtaining excellent yields
and stereoselectivities. 3-Methyl-4-arylidene-pyrazo-
lones gave the best results. Ethyl and phenyl substitu-
tion at position 3 was also tolerated although the yield
and ee slightly decreased. Pyrazolones that have
Scheme 16. Asymmetric addition of diarylphosphine oxides to
4-arylidene-pyrazolones.
Scheme 17. Asymmetric sequential Michael/Michael/Aldol re-
action of 1,3-dicarbonyl compounds with 4-arylidene-pyrazol-
5-ones and α,β-unsaturated aldehydes.
Scheme 18. Asymmetric cycloaddition of malononitrile and 4-
arylidene-pyrazol-5-ones under different conditions.
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electron-withdrawing groups attached to the double
bond gave higher yields but lower enantiomeric
excesses, and similarly happened when this was an
ortho-substituted phenyl group. Remarkably, not only
arylketones but also esters were suitable aminoalkene
substrates in this reaction (Scheme 20).
In 2015, a related asymmetric oxa-Michael/Michael
cascade reaction between 4-arylidene-pyrazolones and
2-nitrovinylphenols was described by Miao.[36] The
products containing the spiro[chroman-3,3’-pyrazol]
scaffold were obtained in excellent yields and enantio-
meric excesses when carbohydrate/cyclohexane-1,2-
diamine thiourea C18 was employed as catalyst. The
use of benzenesulfonic acid (BSA) contributed to
improve the diastereoselectivity. Under the optimal
conditions, some 2-nitrovinylphenols were tested
achieving high to excellent results. Aryl rings bearing
electron-donating and electron-withdrawing groups in
R1 were well tolerated while a furyl substituent gave
lower stereoselectivity. Furthermore, the nitrostyrene
partner tolerated groups of different electronic nature
on the aromatic ring (Scheme 21).
A related organocatalytic thia-Michael/Michael re-
action was developed by Lattanzi in 2017.[37] The
reaction between tert-butyl (E)-4-mercapto-2-bute-
noates and 4-arylidene-pyrazolones using the (R,R)-
ethylendiamine-derived thiourea C19 as catalyst pro-
vided highly functionalized spiro[pyrazolone-4,3’-tetra-
hydrothiophenes] bearing three consecutive stereocen-
ters in good yields and fairly good diastereo-and
enantioselectivities. The tert-butyl ester moiety was
required to obtain high enantiomeric excesses. The
reaction worked well with 4-arylidene-pyrazolones
bearing meta- or para-substituted phenyl rings attached
to the double bond (except p-CN) (Scheme 22).
Later this year, 4-hydroxycoumarins were used as
dinucleophiles in an asymmetric Michael addition/I2-
mediated cyclization reaction with 4-arylidene-pyrazo-
lones reported by Xu.[38] Spiro[dihydrofurocoumarin/
pyrazolone] compounds were obtained in moderate to
excellent yields with excellent diastereoselectivities
and good to excellent enantioselectivities in the
presence of a quinine-derived squaramide C20 as
catalyst. Generally, 4-arylidene-pyrazolones having
electron-rich aryl rings attached to the double bond
gave better enantioselectivities than those bearing
electron-withdrawing groups. Additionally, an ethyl
group in R2 instead of methyl produced a slight
decrease in the ee of the product. Moreover, C7-
substituted 4-hydroxycoumarins provided better yields
than their C6-substituted analogues (Scheme 23).
The authors suggested a plausible mechanism as
depicted in Scheme 23. In the first Michael addition
step, the 4-hydroxycoumarin would be activated by
hydrogen-bonding between the catalyst protonated
amine and the two oxygen atoms at the time that the
pyrazolone would be activated by the squaramide
moiety, driving the approach of the coumarin to the
Re-face of the pyrazolone double bond. The catalyst
also directed the approach of I2 in the cyclization step,
which after an electrophilic/nucleophilic substitution
sequence driven by HI loss would give the spirocyclic
product.
The reaction also worked with 4-hydroxy-6-methyl-
2-pyrone, which was evaluated with different 4-
Scheme 19. Cascade aza-Michael/Michael addition of 2-tosyla-
minoenones and 4-arylidene-pyrazol-5-ones.
Scheme 20. Asymmetric synthesis of chiral spiropyrrolidine-
pyrazolones.
Scheme 21. Asymmetric oxa-Michael/Michael cascade reaction
of 4-arylidene-pyrazolones and 2-nitrovinylphenols.
Scheme 22. Asymmetric thia-Michael/Michael reaction be-
tween (E)-4-mercapto-2-butenoates and 4-arylidene-pyrazo-
lones.
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arylidene-pyrazolones. The desired products were
achieved in high yields (80-90%), high to excellent
enantiomeric excesses (80–96%) and excellent diaster-
eomeric ratios (97:3 to >99:1) (Scheme 24).
An extension of this one-pot methodology using
1,3-diketones was reported by the same group cata-
lyzed by a related squaramide C21.[39] Spiropyrazo-
lones were obtained in excellent yields, diastereoselec-
tivities and enantiomeric excesses. 3-Methyl- and 3-
ethyl-4-arylidene-pyrazolones substituted at the double
bond with aryl groups of different character were
suitable substrates. Cyclic 1,3-diketones gave excellent
results unlike acetylacetone that furnished the product
with good yield but low stereoselectivity (Scheme 25).
In 2018, Pan developed an asymmetric oxa-
Michael/Michael reaction between 4-arylidene-pyrazo-
lones and γ-hydroxyenones to construct chiral spirote-
trahydrofuran-pyrazolones.[40] Two different squara-
mides C20 and C22 were used as optimal catalysts,
depending on the substituents of both reaction partners.
A number of γ-hydroxyenones having aryl or alkyl
groups attached to the ketone gave excellent results
with catalyst C20. Moreover, γ-hydroxyesters could
also participate in the reaction although with modest
enantioselectivity. On the other hand, squaramide C22
was employed for the study of differently substituted
4-arylidene-pyrazolones with the phenyl ketone
(R4=Ph) to give the reaction products with excellent
enantiomeric excesses (Scheme 26).
The reaction of 4-arylidene-pyrazolones with α-
nitroketones has been reported by Pan in 2017. 3-
Acyloxypyrazoles were obtained with excellent yields
and enantiomeric excesses through a Michael/hemi-
ketalization/retro-aldol reaction in the presence of a
tert-leucine-derived bifunctional thiourea C23 in
PhCF3.[41] Good results were obtained with 4-aryli-
dene-pyrazolones substituted at the double bond with
aromatic rings of different electronic features. More-
over, a wide variety of α-nitroketones were well
tolerated (Scheme 27). The nitro group could be
successfully reduced to the corresponding amine using
NiCl2 ·6H2O and NaBH4 in methanol without loss of
enantiomeric excess.
The asymmetric Weitz   Scheffer epoxidation of 4-
arylidene-pyrazolones using tert-butyl hydroperoxide
as oxidant has been reported (Scheme 28).[42] Lattanzi
Scheme 23. Asymmetric Michael addition/I2-mediated cycliza-
tion reaction of 4-hydroxycoumarins and 4-arylidene-pyrazo-
lones.
Scheme 24. Asymmetric Michael addition/I2-mediated cycliza-
tion reaction of 4-hydroxy-6-methyl-2-pyrone and 4-arylidene-
pyrazolones.
Scheme 25. Asymmetric reaction of 1,3-diketones and 4-aryli-
dene-pyrazolones.
Scheme 26. Synthesis of spirotetrahydrofuran-pyrazolones via
an oxa-Michael/Michael reaction.
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and co-workers developed this organocatalyzed reac-
tion involving an oxa-Michael/ring closure sequence.
Herein, the ratio of cis/trans epoxides is controlled by
the ring closure step where the organocatalyst plays a
critical role.
The trans epoxide was obtained as the major isomer
when ethylendiamine derived catalyst C24 was em-
ployed. On the other hand, Cinchona alkaloid-derived
thiourea C25 led mostly to the cis epoxide. In both
cases, the desired epoxides were obtained in high
yields and stereoselectivities regardless of the elec-
tronic and steric features of the pyrazolone substitu-
ents. DFT studies demonstrated that the organocatalyst
played a pivotal role in the reaction mechanism and
that the oxa-Michael addition step was the enantiose-
lectivity and rate-determining step.
Bifunctional catalyst C20 was also effective in the
synthesis of tricyclic compounds with the bispiro[γ-
butyrolactone-pyrrolidin-4,4’-pyrazolone] scaffold
through an asymmetric formal 1,3-dipolar cycloaddi-
tion between α-imino-γ-lactones and 4-arylidene-pyr-
azolones reported by Cai.[43] Under mild conditions,
the desired products were obtained with excellent
results, supporting a broad variety of 4-arylidene-
pyrazolones and α-imino-γ-lactones. Short aliphatic
chains in R2 gave the best results and substitution in R1
and R3 did not affect the reactivity. Unfortunately, α-
imino-γ-lactones with bulky R4 substituents gave
diminished diastereo- and enantioselectivity
(Scheme 29).
The 1,3-dipolar cycloaddition of N-(2,2,2-trifluor-
oethyl)isatin ketimines and 4-arylidene-pyrazolones
was developed by the group of Yan to obtain
trifluoromethylated spirooxindole-pyrrolidine-pyrazo-
lone compounds. Again a Cinchona alkaloid squara-
mide C26 was used as catalyst.[44] Some isatin
ketimines were evaluated obtaining the best results
with those bearing electron-donating groups on the
aromatic ring and a methyl group at the nitrogen atom.
Furthermore, a variety of 4-arylidene-pyrazolones
were tested observing that the substitution in R1, R2
and R3 did not affect significantly the stereoselectivity
(Scheme 30).
Chandra reported in 2019 the asymmetric cyclo-
addition of allenoates with 4-arylidene-pyrazolones.
The reaction took place through a cascade Michael
addition/oxa-Michael cyclization catalyzed by easily
accessible quinidine (C27).[45] The reaction afforded
the desired tetrahydropyrano-pyrazoles in moderate to
high yields. The enantioselectivity of the reaction was
highly dependent on the substituent attached to the
double bond of the pyrazolone, with the ee dropping
when this was an electron-poor aryl group. Allenyl
ketones could be also employed (Scheme 31).
Scheme 27. Asymmetric addition of α-nitroketones to 4-aryli-
dene-pyrazolones.
Scheme 28. Asymmetric epoxidation of 4-arylidene-pyrazo-
lones.
Scheme 29. Asymmetric formal 1,3-dipolar cycloaddition of α-
imino-γ-lactones and 4-arylidene-pyrazolones.
Scheme 30. Asymmetric cycloaddition of N-(2,2,2-trifluoroeth-
yl)isatin ketimines and 4-arylidene-pyrazolones.
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Later that year, Lattanzi and co-workers developed
an asymmetric synthesis of fused pyrazolone-spirocy-
clohexeneimines using Takemoto thiourea C28 as
catalyst.[46] The reaction of (dihydronaphthalen-1(2H)-
ylidene) malononitriles with arylidene-pyrazolones
took place via a vinylogous Michael/cyclization
cascade process under mild conditions to give the
corresponding products with good yields and enantio-
selectivities but with poor diastereoselectivity. The best
results were obtained with 4-arylidene-pyrazolone
having p-substituted aryl groups attached to the double
bond. Remarkably, α,α-dicyanoalkylidene-s derived
from acyclic aromatic and heteroaromatic methyl
ketones provided the spirocyclic products also with
high diastereoselectivity (Scheme 32).
The reaction of 2-(1-methyl-2-oxoindolin-3-yl)
malononitriles with 4-arylidene-pyrazolones has been
developed by Du to obtain spirooxindole-
spiropyrazolones.[47] The reaction, catalyzed by the
quinine-derived squaramide C20, gave the reaction
products with high to excellent yields and excellent
stereoselectivities with diastereomeric ratios above
20:1 and enantiomeric excesses above 98%. Further-
more, 4-aryliedene-pyrazolones substituted with elec-
tron-withdrawing and electron-donating groups in
either R1 or R2 gave excellent results regardless of the
substitution pattern (Scheme 33).
2.1.5. Isothiourea-Catalyzed Reactions
Isothiourea catalysis is another powerful enantioselec-
tive organocatalytic method to promote reactions with
carboxylic acid derivatives via acyl activation. Using
this kind of catalysis Pericàs developed a synthesis of
functionalized dihydropyrano-pyrazolones through a
formal [4+2] cycloaddition of arylacetic acids and 4-
arylidene-pyrazolones. The reaction also worked with
5-arylidene-thiazol-4-ones to give the corresponding
spirothiazolones (Scheme 34).[48] A polystyrene-sup-
ported isothiourea C29 was used and the reaction could
be performed in batch or flow conditions. Awide range
of 4-arylidene-pyrazolones and substituted phenylace-
Scheme 31. Asymmetric cascade Michael addition/oxa-Michael
cyclization of allenoates and 4-arylidene-pyrazolones.
Scheme 32. Synthesis of fused pyrazolone-spirocyclohexenei-
mines from benzylidene-malononitriles and 4-arylidene-pyrazo-
lones.
Scheme 33. Asymmetric formal [3+2] cycloaddition of 2-(2-
oxoindolin-3-yl)malononitriles and 4-arylidene-pyrazolones.
Scheme 34. Asymmetric [4+2] cycloaddition of arylacetic
acids and 4-arylidene-pyrazolones.
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tic acid derivatives was tested obtaining in all cases
high yields and diastereomeric ratios and excellent
enantiomeric excesses. Furthermore, a range of sub-
stituted aromatic arylacetic acids gave excellent results
regardless of the electronic character of the substituent.
The proposed catalytic cycle involves the initial
formation of a mixed anhydride from the arylacetic
acid and pivaloyl chloride, followed by formation of
an acyl ammonium species with the thiourea catalyst.
This is deprotonated by the pivalate to generate an
enolate, which undergoes stereoselective conjugate
addition, followed by lactonization to give the reaction
product and release the catalyst (Scheme 34).
Disubstituted 4-arylidene-pyrazolones, which
would provide a quaternary stereocenter, were also
evaluated although higher catalytic load (20 mol%)
was required. Although most disubstituted alkylidene
pyrazolones did not engage in the reaction or gave low
yields under these conditions, the less sterically
demanding isatin-derived 4-arylidene-pyrazolones
gave the best results giving rise to the spirocyclic
oxindoles with high yield, moderate diastereoselectiv-
ity and excellent enantioselectivity (Scheme 35).
2.2. Palladium-Catalyzed Reactions with 4-Ylidene-
Pyrazolones
Although most of the reactions with 4-ylidene-pyrazo-
lones have been carried out under organocatalytic
conditions, recently, Guo and co-workers reported a
palladium-catalyzed asymmetric [4+2] cycloaddition
of 5-methylene-1,3-dioxan-2-one with 4-arylidene-pyr-
azolones and other cyclic alkenes.[49] With 4-arylidene-
pyrazolones the best results were achieved with
[Pd2dba3] ·CHCl3 in mesitylene using (R)-DTBM-
Segphos as ligand. Under these conditions, a broad
variety of 4-arylidene-pyrazolones were studied, ob-
taining in all cases excellent yields and stereoselectiv-
ities. 4-Arylidene-pyrazolones substituted at C3 with
methyl or ethyl groups gave excellent results. A n-
propyl group at this position was also tolerated.
Remarkably, indandione and barbiturate-derived al-
kenes were also studied under modified conditions
(changing the amount of palladium and ligand),
obtaining high to excellent yields and excellent
enantiomeric excesses (Scheme 36).
3. 4-Ylidene-Isoxazolin-5-Ones
Isoxazolin-5-ones are versatile five-membered hetero-
cycles that can be found in natural products isolated
from bacteria,[50] fungi,[51] insects[52] or seedlings.[53]
This moiety an its derivate 4-ylidene-isoxazolin-5-one
are present in some biologically active compounds
including anti-fungal agents,[54] PTP1B inhibitors with
anti-obesity activity,[55] antimicrobial agents[56] or anti-
cancer agents.[57] Moreover, the 4-ylidene-isoxazolin-5-
one core is present in new photoluminescent
materials[58] and donor-acceptor molecules that can act
as dyes (Figure 3).[59]
Furthermore, the isoxazol-5-one ring is a useful
building block, which can be converted into different
Scheme 35. Asymmetric [4+2] cycloaddition of arylacetic
acids and disubstituted 4-arylidene-pyrazolones.
Scheme 36. Asymmetric [4+2] cycloaddition of 5-methylene-
1,3-dioxan-2-one with 4-arylidene-pyrazolones.
Figure 3. Selected examples of interesting compounds contain-
ing the isoxazolin-5-one scaffold.
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structural motifs.[60] Asymmetric addition reaction to 4-
ylidene-isoxazolin-5-one followed by a nitrosative
cleavage allows the synthesis of branched alkynes.
Further, taking the advantage of the weak N   O bond
strength, a reductive protocol using iron can selective
transforms the isoxazol-5-one ring into a ketone
(Scheme 37).[61] Due to their potential applications, 4-
ylidene-isoxazolin-5-ones have emerged as powerful
1,4-acceptors in asymmetric additions. Nucleophilic
addition to the double bond is favored by resonance
stabilization of the resulting carbanion, which is
delocalized to the imine and carbonyl groups. The
nucleophilic character of this carbanion allows the
development of formal cycloaddition reactions in
domino processes, normally with formation of a
quaternary stereogenic center at C-4.[62] Participation of
the carbonyl oxygen in these domino processes is
hampered because the charge in the carbanion inter-
mediate is concentrated on the C-4 and N atoms of the
heterocycle. Hence, 4-arylidene-isoxazolin-5-ones do
not often participate as heterodienes in cycloaddition
reactions unlike 4-ylidene-pyrazol-5-ones and other
ylidene-heterocycles presented in this review. Finally,
as 4-ylidene-pyrazol-5-ones, 4-ylidene-isoxazolin-5-
ones also prefer the exocyclic double bond with the Z-
configuration despite being represented sometimes
with the E-configuration.
3.1. Organocatalytic Reactions with 4-Ylidene-Iso-
xazolin-5-Ones
3.1.1. Brønsted Base and Bifunctional Hydrogen-
Bonding/Brønsted Base Catalysis
To the best of our knowledge, only organocatalytic
methodologies have been applied in asymmetric
reactions involving 4-ylidene-isoxazolin-5-ones. Bi-
functional catalysis and enamine catalysis have been
the most frequently applied approaches in these cases.
In 2014, the group of Yuan reported the quinine-
catalyzed synthesis of spirocyclic oxindoles with three
consecutive stereocenters via an asymmetric Michael/
cyclization reaction with 3-isothiocyanato oxindoles as
formal dipoles. 4-Arylidene-pyrazol-5-ones and 4-
arylidene-isoxazolin-5-ones were used as
dipolarophiles.[63] In both cases, the reaction products
were obtained with good yields moderate diastereose-
lectivities and fair to good enantiomeric excesses, that
were higher with pyrazolones than with isoxazolinones
(Scheme 38).
Recently, our group developed an asymmetric [3+
2] cycloaddition between 4-ylidene-isoxazolinones and
isocyanoacetates esters catalyzed by a chiral squar-
amide C30 and silver oxide.[64] This cooperative
system gave functionalized diazaspirocycles with high
to excellent yields and high stereoselectivities. A broad
variety of 4-ylidene-isoxazolinones were evaluated
obtaining excellent results regardless of the electronic
and steric effect of the substituents in the R2 aromatic
rings. Moreover, a R2 cyclopropyl group was well
tolerated. The highest enantiomeric excesses were
obtained with 5-methyl-4-arylidene-isoxazolinones
(R1=Me). Benzyl isocyanoacetate performed similarly
to the methyl ester (Scheme 39). During this research,
it was noticed that 4-ylidene-isoxazolinones decom-
posed in dichloromethane solution, an issue that could
be alleviated by reducing the concentration of the
reaction mixture.
The ability of 4-arylidene-isoxazolinones to partic-
ipate in asymmetric formal [3+2] cycloadditions has
been also demonstrated by Du.[65] The authors reported
a squaramide-catalyzed tandem Michael/Michael reac-
tion between 3-((2-oxoindolin-3-yl)oxy)acrylates and
4-arylidene-isoxazolinones obtaining isoxazolone-spi-
rooxindoles with excellent results (Scheme 40).
The reaction tolerated a broad variety of allyl and
aromatic substituents in R2. Unfortunately, only exam-
ples featuring a methyl or ethyl group at position 3 in
the isoxazolinone ring were reported. On the other
Scheme 37. Reactivity of 4-ylidene-isoxazolin-5-ones.
Scheme 38. Domino Michael/cyclization reaction between 3-
isothiocyanato oxindoles and 4-arylidene-pyrazolones or 4-
arylidene-isoxazolinones.
Scheme 39. Asymmetric [3+2] cycloaddition between 4-
ylidene-isoxazolinones and isocyanoacetates esters.
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hand, a wide range of 3-((2-oxoindolin-3-yl)oxy)
acrylates bearing different substitution at the aromatic
ring were also well tolerated (Scheme 40).
Besides these formal cycloaddition reactions, the
single asymmetric addition of malonates to 4-ylidene-
isoxazolin-5-ones was studied by Massa using quini-
dine as catalyst (Scheme 41).[66] Once the adduct is
formed, a purification challenge appeared due to the
rapid isomerization of the isoxazolinone ring that led
to a mixture of all the possible isomers. So, a N-
trapping method was also developed founding Boc2O
as the best trapping agent. With these conditions in
hand, a good number of 4-arylidene-isoxazolinones
was studied obtaining the best results with bulkier
substituents in R1. Conversely, small alkoxy groups in
the malonate ester led to better yields and enantiomeric
excesses.
3.1.2. Reactions via Enamine Catalysis
Enamine catalysis using a chiral primary amine is
especially useful when starting materials bearing a
carbonyl group in their structures are used. In 2017,
Jurberg described an asymmetric Michael addition of
ketones to 4-ylidene-isoxazolinones using a Cinchona
alkaloid-derived amine C31 as the catalyst
(Scheme 42).[67] The p-trifluoromethylbenzoic acid co-
catalyst was needed to increase both the yield and the
enantiomeric excess. The reaction worked with a
number of cyclic and acyclic ketones, usually with
good diastereo-and enantioselectivity. With non-sym-
metrical ketones, the reaction took place by the least
substituted α-carbon. Cyclohexanone was tested with
several 4-ylidene-isoxazolinones observing good toler-
ance regarding the substituents in both the imine and
the double bond. The isoxazolinone ring was trans-
formed into an alkyne by a nitrosative cleavage using
FeSO4 ·7H2O, NaNO2 and AcOH/H2O, thus obtaining
the corresponding alkyne with two consecutive stereo-
centers.
One year later, Chen and Ouyang studied a regio-
and diastereodivergent [4+2] cycloaddition of cyclic
2,4-dienones catalyzed by a bifunctional amine-thiour-
ea C32.[68] In this work, a wide variety of heterocyclic
electrophiles is studied, but, paying attention to 4-
ylidene-isoxazolinones three important types of reac-
tion were developed. The addition of 2,4-dienones to
4-ylidene-isoxazolinones was first studied. The reac-
tion was carried out in the presence of benzoic acid as
co-catalyst, obtaining fair to good yields of spirotricy-
clic compounds with excellent diastereoselectivities
and enantiomeric excesses (Scheme 43).
Furthermore, the authors found that the same
catalytic system allowed the three-component reaction
between 3-methylisoxazolin-5-one, 2,4-dienones and
benzaldehyde. In this case, the 4-ylidene-isoxazoli-
nones are generated in situ. 4 Å Molecular sieves was
needed to increase the yield and the enantiomeric
excess (Scheme 44).
Going further, a four component cascade reaction
involving the in situ formation of both, the 4-aryli-
dene-isoxazolinone and the 2,4-dienone was studied.
In this case, a Cinchona alkaloid amine was also
Scheme 40. Asymmetric [3+2] cycloaddition between 4-
ylidene-isoxazolinones and 3-((2-oxoindolin-3-yl)oxy)acrylates.
Scheme 41. Asymmetric addition of malonates to 4-arylidene-
isoxazolinones.
Scheme 42. Enamine-catalyzed addition of ketones to 4-
ylidene-isoxazolinones.
Scheme 43. Asymmetric formal [4+2] cycloaddition of 2,4-
dienones and 4-arylidene-isoxazolinones.
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required to form the 2,4-dienone. The reaction occurs
in moderate yields, excellent diastereoselectivities and
good enantiomeric excesses (Scheme 45).
Recently, a novel formal [4+2] cycloaddition
leading to chiral spiroisoxazol-5-ones has been devel-
oped by Jurberg through enamine catalysis.[69] Quini-
dine amine C3 and benzoic acid catalyzed the
cyclization reaction between methyl vinyl ketones and
4-arylidene-isoxazolin-5-ones. Remarkably, a methyl
group at the C3 position of the 4-arylidene-isoxazoli-
none was required to obtain exclusively the 6,10-trans-
spiroisoxazol-5-ones, while compounds having an aryl
or isopropyl group at this position gave the cis-
isomers, either achiral or in a racemic form. DFT
calculations demonstrated that apolar solvents and
short reaction times favored the 6,10-trans-spiroisox-
azol-5-one (kinetic control) while polar solvents and
larger reaction times favored the 6,10-cis-spirisoxazol-
5-one (thermodynamic control) in a racemic fashion.
In the enantioselective reaction, a number of 4-
arylidene-isoxazolinones and methyl arylvinyl ketones
were tested obtaining high yields and excellent
enantiomeric excesses (Scheme 46).
An asymmetric four component cycloaddition in-
volving the in situ formation of 4-arylidene-isoxazoli-
nones and α’-arylidene-3-substituted 2-cyclopente-
nones has been reported by Du and Chen.[70] This [5+
1+1+1] formal cycloaddition was catalyzed by a
chiral amine C35 in the presence of p-methylsalicylic
acid (A1) as co-catalyst (Scheme 47). 3-Meth-
ylisoxazolinone and 3-phenylisoxazolinone were used
together with 3-substituted 2-cyclopentenones and
aldehydes as starting materials. The spirocyclic prod-
ucts were obtained in fair to good yields, excellent
diastereoselectivities and good to excellent enantiose-
lectivities. The authors proposed a mechanism where
the enamine of the 2-cyclopentenone would attack the
4-arylidene-isoxazolinone (generated in situ) in a Mi-
chael addition fashion, which after a retro-Michael
reaction would give an α’-arylidene-3-substituted 2-
cyclopentenone and recover the initial isoxazolinone.
Then, the formed cyclopentadienone would react, via
enamine catalysis with another molecule giving the
cycloaddition product.
Scheme 44. Three-component reaction between isoxazolinones,
2,4-dienones and benzaldehyde.
Scheme 45. Asymmetric four-component reaction.
Scheme 46. Asymmetric cycloaddition between methyl arylvin-
yl ketones and 4-arylidene-isoxazolinones.
Scheme 47. Asymmetric four-component cycloaddition be-
tween isoxazolinones, 3-cyclopentanones and aldehydes.
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4. 4-Ylidene-2,3-Dioxopyrrolidines
Five-membered ring lactams also named γ-lactams or
2-oxopyrrolidines can be found in natural products[71]
and some drugs as piracetam.[72] When a carbonyl
group is incorporated in position 3 of the ring, a new
biologically active moiety named 2,3-dioxopyrrolidine
appears. These heterocycles can be found in natural
products,[73] and compounds that are used as
anticoagulants,[74] antitumor[75] or glucokinase activa-
tors to regulate the type II diabetes mellitus.[76] More-
over, these compounds have been used in the synthesis
of novel antifungals (Figure 4).[77]
The 4-ylidene-2,3-dioxopyrrolidines have different
reactive sites, which allows the synthesis of diverse
structures through different addition and cycloaddition
reactions. These compounds can react as monoenes in
Michael addition reactions, and as 4π oxa-dienes or 2π
dienophiles in cycloaddition reactions that can be
initiated by nucleophilic addition to the double bond.
In these cases, the C3-carbonyl enolate carbonyl is
stabilized by conjugation of the double bond with the
amide carbonyl, rendering the oxygen at C3 very
nucleophilic and, hence favoring the the oxa-diene-like
behavior (Scheme 48). Both, transition metal catalysis
and organocatalysis have been used in asymmetric
reactions involving these compounds as substrates.
4.1. Organocatalytic Reactions with 4-Ylidene-
2,3-Dioxopyrrolidines
4.1.1. Brønsted Base and Bifunctional Hydrogen
Bonding/Brønsted Base Catalysis
The first asymmetric organocatalytic reaction with 4-
ylidene-dioxopyrrolidines was described by Xu in
2015.[78] Quinine benzoyl ester C36 catalyzed the
asymmetric formal [4+2] cycloaddition between
allenyl ketones and 4-arylidene-2,3-dioxopyrrolidines
to give fused 4H-pyran-pyrrolin-2-one derivatives,
which were obtained in high yields and good
enantioselectivities. The steric rather than the elec-
tronic characteristics of the aryl group R1 determined
the enantioselectivity of the reaction, the best results
being obtained with meta-and para-substituted 2,3-
dioxopyrrolidines. Alkyl allenones or allene esters
gave poor yields (Scheme 49).
In 2018, Li reported the asymmetric cycloaddition
of α-haloaldehydes and 4-arylidene-2,3-dioxopyrroli-
dines catalyzed by squaramide C20.[79] The key
intermediate in this reaction, an α-halogenated enolate
susceptible to dehalogenation, is stabilized and stereo-
chemically controlled using bifunctional tertiary
amines. The bicyclic dihydropyrans bearing a halogen-
ated quaternary stereocenter were afforded in excellent
yields, high diastereoselectivities and excellent enan-
tiomeric excesses. Furthermore, the bicyclic com-
pounds could be transformed into valuable densely
functionalized spirocyclopropanes, which possess two
contiguous all-carbon quaternary stereocenters, using
DBU in acetonitrile (even in a one-pot fashion) with
good to excellent yields and stereoselectivities
(Scheme 50).
Later in 2020, Du reported a related reaction using
this time 3-chlorooxindoles as pronucleophiles. Again,
the reaction was catalyzed by a bifunctional squar-
amide derivative of quinine C14.[80] The authors found
that the presence of one equivalent of NH4HCO3 wasFigure 4. Examples of bioactive compounds containing the 2-
oxopyrrolidine and 2,3-dioxopyrrolidine motif.
Scheme 48. General reactivity of 2,3-dioxopyrrolidines.
Scheme 49. Asymmetric [4+2] cycloaddition between allenyl
ketones and 2,3-dioxopyrrolidines.
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crucial to obtain the desired bi-spirocyclic products in
high yields, diastereoselectivities and enantiomeric
excesses (Scheme 51). A broad variety of 4-arylidene-
pyrrolidinones were studied obtaining the bispirocyclic
products bearing three adjacent chiral centers with
excellent results (Scheme 51).
In 2019, Huang reported a regiodivergent reaction
between 3-butenyl N-acylpyrazoles and 4-arylidene-
2,3-dioxopyrrolidines catalyzed by a squaramide C37
derived from quinine.[81] The reaction with 4-aryl-3-
butenyl N-acylpyrazoles provided tetrahydropyrano-
pyrolone adducts with excellent results through a
vinylogous Michael addition/oxa-Michael reaction.
Excellent yields, diastereo- and enantioselectivities
were obtained for a range of 4-arylidene-2,3-dioxopyr-
rolidines having aromatic or heteroaromatic rings (R1)
attached to the double bond. The β,γ-unsaturated amide
also tolerated aromatic and heteroaromatic groups R2.
The best results were obtained with amides derived
from 3,5-dimethylpyrazole (Scheme 52).
On the other hand, when 3-aryl-3-butenyl N-
acylpyrazoles were used, spiropyrrolidinone-dihydro-
pyranones were obtained in excellent yields and
enantiomeric excesses via a 1,2-selective γ-addition to
the ketone carbonyl of the dioxopyrrolidine ring
followed by cyclization. The 3-substituted-3-butenyl
N-acylpyrazoles did not perform as β,γ-regioselective
dienophiles, because of the formation of a demanding
steric hindered quaternary stereogenic carbon at posi-
tion 3. In this case, the steric hindrance of the
substituent in R1 had a slightly negative effect in the
enantiocontrol, although both electron-poor and elec-
tron-rich substituents were well tolerated. In addition,
good results were obtained with 3-butenyl N-acylpyr-
azoles bearing different aryl rings or a methyl group at
position 3 (Scheme 53).
Using this catalyst, the same authors also developed
an asymmetric formal [4+2] cycloaddition of 4-
arylidene-2,3-dioxopyrrolidines and azlactones.[82] The
reaction proceeded well with 2,3-dioxopyrrolidines
containing different aromatic substituents in R1 and
azlactones having benzyl, alkyl or halophenyl groups
at R2 and a para-methoxyphenyl ring (PMP) attached
to the imine carbon, other aromatic rings at this
position were tolerated but led to lower enantiomeric
excesses. The corresponding pyrano[2,3-c]pyrrole
products were obtained in high yields and excellent
diastereoselectivities (>20:1). Two plausible mecha-
nisms were also proposed: (i) involving a conjugate
addition of the azlactone to the 4-arylidene-dioxopyr-
rolidinone followed by an intramolecular cyclization,
and (ii) involving an inverse-electron-demand hetero-
Diels-Alder reaction that proceeds in an endo way
followed by ring opening (Scheme 54).
A modularly designed organocatalyst, self-as-
sembled in situ from a thiourea derived from quinine
C25 and L-proline, was developed by Huang for the
synthesis of a series of fused tricyclic pyrano[3’,2’:5,6]
pyrano[2,3-c]pyrrolones.[83] The reaction involved 4-
arylidene-2,3-dioxopyrrolidines and aldehydes featur-
ing a properly positioned enone moiety in their
structure, leading to the reaction products through a
Michael addition/acetalation/oxa-Michael process. The
Scheme 50. Asymmetric cyclopropanation of 4-alkylidene-2,3-
dioxopyrrolidinones with α-haloaldehydes.
Scheme 51. Asymmetric cyclopropanation of 4-arylidene-2,3-
dioxopyrrolidines with 3-chlorooxindoles.
Scheme 52. Asymmetric vinylogous Michael addition/oxa-Mi-
chael reaction between 4-aryl-3-butenyl N-acylpyrazoles and 4-
arylidene-2,3-dioxopyrrolidines.
Scheme 53. Asymmetric 1,2-γ-addition/cyclization between 3-
aryl-3-butenyl N-acylpyrazoles and 4-arylidene-pyrrolidinones.
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tricyclic compounds were obtained in excellent yields,
diastereoselectivities and enantiomeric excesses
(Scheme 55).
A diastereodivergent and enantioselective formal [3
+2] cycloaddition reaction between N-(2,2,2-trifluor-
oethyl)isatin ketimines and 4-alkylidene-dioxopyrroli-
dinones has been developed by the group of Jiang.[84]
Initial studies demonstrated that a quinine derived
squaramide C39 was the best catalyst and benzoic acid
was needed to increase both chemical yield and
enantiomeric excess. Furthermore, it was found that
the reaction time and the ratio catalyst/benzoic acid
played an essential role in the formation of one or
another epimer. Thus, long reaction times (96 h),
10 mol% of catalyst and three equivalents of benzoic
acid led to preferential formation of the α epimer
(Scheme 56).
On the other hand, when a 30 mol% of C39, 1.5
equivalents of benzoic acid and shorter reaction times
(9 h) were used, the β epimer was obtained as the
major isomer. In both cases, the reaction allowed the
use of different N-(2,2,2-trifluoroethyl)isatin ketimines
as well as 4-arylidene-2,3-dioxopyrrolidines, and the
bi-spirocyclic oxindoles were obtained in moderate to
excellent yields, diastereoselectivities and enantiomeric
excesses (Scheme 57).
Finally, an asymmetric conjugate addition of nitro-
alkanes to 4-arylidene-2,3-dioxopyrrolidines and 4-
arylidene-dihydrofuran-2,3-diones catalyzed by bifunc-
tional squaramide C20 has been recently published by
Bugaut and co-workers.[85] The authors found better
results with 4-arylidene-2,3-dioxopyrrolidines than
with 4-arylidene-dihydrofuran-2,3-diones. The reaction
was tested with differently substituted nitroalkanes,
obtaining the highest yields and enantiomeric excesses
with nitroethane, although diastereoselectivities were,
in general, low (Scheme 58). When 2-nitro-1-phenyl-
ethanone (R2=PhCO) was used, the Michael addition
was followed by C-to-O benzoyl migration in a similar
manner as in the reaction with pyrazolones (see
Scheme 27).
Scheme 54. Asymmetric synthesis of pyrano[2,3-c]pyrroles
from azlactones and 4-arylidene-dioxopyrrolidines.
Scheme 55. Synthesis of fused tricyclic acetals.
Scheme 56. Asymmetric diastereodivergent [3+2] cycloaddi-
tion of isatin ketimines and 4-arylidene-pyrrolidinones (α
epimer).
Scheme 57. Asymmetric diastereodivergent [3+2] cycloaddi-
tion of isatin ketimines and 4-arylidene-pyrrolidinones (β
epimer).
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4.1.2. Reactions via Enamine Catalysis
2,3-Dioxopyrrolidines have been used as heterodienes
in the inverse-electron-demand oxa-Diels-Alder reac-
tion with enolizable aldehydes via enamine catalysis
by Gou and Peng.[86] Fused bicyclic dihydropyrans
were obtained in good yields with good diastereose-
lectivities and high enantiomeric excesses using the
Hayashi-Jørgensen catalyst C1 and benzoic acid as co-
catalyst. The reaction could be carried out with a
variety of aliphatic aldehydes and with a good number
of N-benzyl 4-arylidene-2,3-dioxopyrrolidines bearing
differently substituted aromatic and heteroaromatic
groups R1 attached to the double bond (Scheme 59).
Remarkably, the authors could adjust the reaction
conditions to carry out the reaction with aqueous
acetaldehyde. An acetylation-chlorination reaction of
the resulting bicyclic trans-dihydropyranones was then
performed giving chloro-substituted products with
configurational retention (Scheme 60).
4.1.3. Phosphine and Phosphonium Salt Catalyzed
Reactions
Asymmetric cycloaddition reactions using 4-ylidene-
2,3-dioxopyrrolidines have been also achieved with
phosphine catalysis. In 2017, Guo reported the asym-
metric [4+2] cycloaddition of α-substituted allenoates
with 4-arylidene-pyrrolidine-2,3-diones catalyzed by
an amino acid-derived chiral phosphine C40.[87] The
reaction required 4 Å molecular sieves as additive to
obtain the desired products in high yields and good
enantiomeric excesses. Fused pyrrolidinone-dihydro-
pyran derivatives were afforded in moderate to good
yields and excellent enantioselectivities (Scheme 61).
A broad variety of 4-arylidene-2,3-dioxopyrrolidines
having aromatic rings attached to the double bond
were supported, observing a slight decrease in the yield
with those being ortho or meta substituted. On the
other hand, a benzylic substituent at the α-position of
the allenoate was required, no reaction being observed
when this was a methyl group (R2=H)
In 2019, a new C2-symmetric chiral phosphine C41
was employed to catalyze the highly enantioselective
domino process involving 4-arylidene-2,3-dioxopyrro-
lidines and γ-substituted allenoates to afford tricyclic
γ-lactams with five contiguous stereogenic centers.[88]
A variety of 4-arylidene-dioxopyrrolidines were good
substrates for the reaction. The R2 substituent on the
allenoate could be either an aryl, alkyl or an ester
group. In this reaction, the phosphine catalyst gener-
ates a δ-anion that undergoes a Michael addition to the
2,3-dioxopyrrolidine. Once the Michael addition oc-
curs, a H-shift allows the intramolecular addition over
the carbonyl group of the 2,3-dioxopyrrolidine hetero-
cycle. Then, an intramolecular oxa-cycloaddition deliv-
ers the desired tricyclic γ-lactam (Scheme 62).
Recently, Wang and Gao have studied the asym-
metric 1,3-dipolar cycloaddition of N-(2,2,2-trifluor-
oethyl)isatin ketimines and 4-alkenyl-2,3-
dioxopyrrolidines.[89] This reaction was successfully
catalyzed by a dipeptide-derived phosphonium salt
C42 under phase-transfer conditions (PTC), and
provided CF3-substituted 3,2’-pyrrolidinyl spirooxin-
doles. A good number of 4-arylidene-pyrrolidinones
and substituted isatin ketimines were tested to give the
desired products in high yields, as a single diaster-
eomer with high enantiomeric excesses (Scheme 63).
Mechanistic study experiments revealed that the
stereocontrol of the reaction is due to a hydrogen-
bonding coordination of the peptide NH with the
carbonyl oxygen atoms of the dioxopyrrolidine core
and ion pairing between the phosphorous cation and
the isatin ketimine anion.
The same group also reported enantioselective PTC
in the reaction of 4-bromopyrazolones and 4-arylidene-
dioxopyrrolidines using another dipeptide-derived
Scheme 59. Asymmetric inverse-electron-demand oxa-Diels-
Alder between enolizable aldehydes and 4-yliene-2,3-dioxopyr-
rolidines.
Scheme 60. Asymmetric inverse-electron-demand oxa-Diels-
Alder between aqueous acetaldehyde and 2,3-dioxopyrrolidines.
Scheme 61. Asymmetric [4+2] cycloaddition of α-substituted
allenoates with 4-arylidene-2,3-dioxopyrrolidines.
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phosphonium salt C43.[90] The reaction involved a
Michael addition of the pyrazolone enolate to the
arylidene-dioxopyrrolidine followed by intramolecular
SN2 to give the formal [2+1] cycloaddition product
containing a cyclopropylspirocyclic moiety. The reac-
tion could be applied to a wide range of 4-arylidene-
2,3-dioxopyrrolidines, and pyrazolones, obtaining in
all the cases excellent yields, diastereoselectivities and
enantioselectivities (Scheme 64).
4.1.4. Reactions via NHC Catalysis
Peng and Shen have reported the asymmetric NHC-
catalyzed formal [4+2] cycloaddition of 4-arylidene-
dioxopyrrolidines and α-haloaldehydes.[91] Bicyclic
dihydropyranones were obtained in high yields and
excellent enantioselectivities. Both electron-donating
and electron-withdrawing groups on the aromatic ring
attached to the double bond of the arylidene-dioxopyr-
rolidine were accepted. Moreover, linear aliphatic or
benzyloxy substituted aldehydes produced the corre-
sponding dihydropyranones with excellent results
(Scheme 65). Remarkably, the substituents on the
lactone ring showed a cis disposition, in contrast with
the trans disposition observed in a related reaction
described by the same group under enamine catalysis
(see Scheme 59).[86]
Another synthesis of these bicyclic dihydropyra-
nones has been described by Wang in 2020.[92] This
asymmetric NHC-catalyzed [4+2] annulation of α-
bromoenals and 2,3-dioxopyrrolidines showed broad
substrate scope and gave the bicyclic products in good
to high yields and excellent enantioselectivities. N-Bn
protected 2,3-dioxopyrrolidines gave the best results
allowing aromatic rings of different substitution pattern
and electronic character attached to the double bond.
Furthermore, α-bromoenals could contain a methyl,
aryl or heteroaryl group R3 on the double bond
(Scheme 66).
Scheme 62. Asymmetric cycloaddition between 4-arylidene-
dioxopyrrolidines and allene esters.
Scheme 63. 1,3-Dipolar cycloaddition between isatin ketimines
and 4-arylidene-dioxopyrrolidines under PTC.
Scheme 64. Asymmetric cyclopropanation of 4-arylidene-2,3-
dioxopyrrolidines with of 4-halopyrazolones.
Scheme 65. Asymmetric [4+2] cycloaddition of α-chloroalde-
hydes to 4-arylidene-dioxopirrolidines.
Scheme 66. Asymmetric [4+2] annulation between α-bromoe-
nals and 4-arylidene-2,3-dioxopyrrolidines.
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4.2. Metal-Catalyzed Reactions with 4-Ylidene-
2,3-Dioxopyrrolidines
The first metal-catalyzed enantioselective reaction
involving the 4-ylidene-2,3-dioxopyrrolidine motif was
described in 2016 by Feng.[93] In this paper, a Diels-
Alder reaction between 4-arylidene-2,3-dioxopyrroli-
dines and cyclopentadiene was achieved using a
complex of Ni(OTf)2 with a N,N’-dioxide ligand L2 as
catalyst. In general, high yields, diastereoselectivities
and enantiomeric excesses of spirocyclic compounds
were obtained with a variety of arylidene-dioxopyrroli-
dine derivatives bearing aromatic groups attached to
the double bond (Scheme 67).
Two years later, a similar Ni catalyst complex with
a L-proline-derived dioxide ligand L3 was used by the
same authors to carry out an inverse-electron-demand
hetero-Diels   Alder reaction.[94] 4-Arylidene-2,3-diox-
opyrrolidines reacted as heterodienes with hetero-
substituted alkenes to give the corresponding fused
pyrano-pyrroles with excellent yields and stereoselec-
tivities, regardless of the electronic or steric features of
the substituents on the exocyclic double bond. Besides
monosubstituted vinyl ethers, N-vinyl carbamates
reacted to give the expected products with good yields,
fair to good diastereoselectivities and high enantiose-
lectivities. A vinyl sulfide as well as disubstituted vinyl
ethers also reacted but with moderated diastereo- and
enantioselectivity (Scheme 68).
In 2020, the conjugate addition of nitroalkanes to 4-
arylidene-2,3-dioxopyrrolidines was reported by Wang
using a copper complex with a proline-derived ligand
L4 in aqueous media.[95] The reaction needed the use
of N-ethylmorpholine as a base and sodium lauryl
sulfate (SLS) as surfactant. A series of nitro-containing
pyrrolidones were prepared in high yields, excellent
diastereoselectivities, and enantiomeric excesses. The
reaction tolerated aromatic rings of diverse nature
attached to the double bond of the arylidene-dioxopyr-
rolidine. On the other hand, the reaction worked better
with nitroethane and nitropropane than with nitro-
methane (Scheme 69).
5. Reactions with Rhodanine and
Oxazolidindione Derivatives
Rhodanine-based compounds have become very im-
portant in drug discovery because of their varied
biological activities.[96] Some of these compounds have
been reported to possess antibacterial,[97] antiviral,[98]
pesticide,[99] antimalarial,[100] antitumor[101] or anti-
inflammatory activity.[102] Furthermore, they can poten-
tially be used in the treatment of diabetes[103] and
Alzheimer,[104] among others. On the other hand, the
oxazolidin-2,4-dione motif can be found in
herbicides,[105] antiepileptic agents,[106] and anti-inflam-
matory drugs.[107] Moreover, this motif is also being
studied for the development of novel photosensitive
dyes (Figure 5).[108]
The oxazolidindione and rhodanine scaffolds bear-
ing exocyclic double bonds have emerged as powerful
substrates in asymmetric cycloaddition reactions pro-
viding highly functionalized spirocompounds.[109]
While organocatalysis has been the most frequently
used with rhodanine derivatives, metal-ligand catalysis
has been also used with oxazolidindione derivatives,
despite examples of organocatalytic asymmetric Mi-
chael additions with these substrates are also known
(Scheme 70).
5.1. Organocatalytic Reactions with 5-Ylidene-Rho-
danines
5-Ylidene-rhodanines have been successfully em-
ployed as substrates in asymmetric cycloaddition
reactions. Organocatalytic methods such as enamine
Scheme 67. Asymmetric Diels-Alder reaction between 4-aryli-
dene-2,3-dioxopyrrolidine and cyclopentadiene.
Scheme 68. Asymmetric inverse-electron-demand hetero-
Diels   Alder reaction.
Scheme 69. Asymmetric addition of nitroalkanes to 4-aryli-
dene-2,3-dioxopyrrolidines.
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and Cinchona alkaloid bifunctional catalysis have been
shown extremely efficient to perform these reactions.
5.1.1. Reactions via Enamine Catalysis
Ye described the first asymmetric reaction involving 5-
ylidene-rhodanines in 2012.[110] A tandem double
Michael addition between 4-ylidene-rhodanines and
enolizable enones was performed using a chiral
primary amine C46 as catalyst in the presence of an
acid additive such as ortho-methoxybenzoic acid or N-
Boc-L-Trp. The substituents on the N atom and double
bond of the rhodanine derivative were amenable to
modification as well as the substituent on the double
bond of the enone. Rhodanine spirocyclic compounds
bearing three (R4=H) or four (R4=Me) stereogenic
centers were obtained with good yields, fair to high
diastereoselectivities and excellent enantiomeric ex-
cesses (Scheme 71).
The same group also described a Diels-Alder
reaction between 2,4-dienals and 5-ylidene-rhodanines
catalyzed by the Hayashi-Jørgensen catalyst C1 and o-
fluorobenzoic acid as co-catalyst.[111] The reaction was
carried out in CDCl3 as the solvent, which apparently
provided the best solubility for the rhodanine and
favored higher yields. The scope and limitations of the
reaction were investigated using first some 5-ylidene-
rhodanines, observing that the substituent R1 has a
high influence in the reaction rate. Long reaction times
(72-96 h) were needed when R1 was an aromatic ring
while shorter reaction times were required when R1
was CO2Et. Remarkably, the structure of R1 had very
limited influence on the stereoselectivity of the
reaction, which afforded the spirocyclic products with
high diastereoselectivities (10:1) and excellent enantio-
meric excesses (>90%). Furthermore, the authors
assayed differently substituted 2,4-dienals obtaining in
all cases high to excellent yields, diastereoselectivities
and enantiomeric excesses (Scheme 72).
5.1.2. Bifunctional Hydrogen-Bonding/Brønsted Base
Catalysis
Cinchona alkaloid derivatives have shown to be
powerful catalysts in asymmetric addition reactions to
rhodanine derivatives. Du and co-workers reported in
2018 an asymmetric formal [3+2] cycloaddition
reaction of N-(2,2,2-trifluoroethyl)isatin ketimines and
5-ylidene-rhodanines involving a domino Michael/
Mannich process (Scheme 73).[112]
The bifunctional squaramide C14 was found as the
best catalyst. An electron-withdrawing group R1 (ester,
Figure 5. Examples of bioactive compounds containing the
rhodanine and oxazolidin-2,4-dione motifs.
Scheme 70. General reactivity of ylidene-derivatives of rhoda-
nine and oxazolidindiones.
Scheme 71. Asymmetric double Michael addition of enolizable
enones to 5-ylidene-rhodanines.
Scheme 72. Asymmetric Diels-Alder reaction between 2,4-
dienals and 5-ylidene-rhodanines.
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CN) attached to the exocyclic double bond of the
rhodanine was required as rhodanines having a phenyl
group did not react. However, a diversity of alkyl and
aryl groups R2 attached to the N atom were tolerated.
On the other hand, the isatin ketimines permitted
different substituents on either the aromatic ring or N1.
In general, the bi-spirocyclic oxindoles were obtained
with high yields, diastereo-and enantioselectivities.
The same authors also studied an asymmetric
cascade aza-Michael/Michael addition reaction be-
tween rhodanine derivatives and β-(2-tosylaminophen-
yl)enones to afford spirothiazolidinone-
tetrahydroquinolines.[113] In this case, squaramide C20
was the best performing catalyst providing the reaction
products with good yields excellent diastereoselectiv-
ities and fair to good enantiomeric excesses. An ester
group attached to the exocyclic double bond and
substitution at the N atom of the rhodanine were
required. On the other hand, the enone required a non-
enolizable group (aryl or tert-butyl) attached to the
carbonyl, as methyl ketone did not react (Scheme 74).
In 2020, the asymmetric [3+3] annulation between
pyrazolones and novel rhodanine ketoesters catalyzed
by the chiral squaramide C20 was described by Xu.[114]
The rhodanine ketoesters played as bis-electrophiles,
and featured two potential hydrogen-bonding activa-
tion sites to favor the reaction and promoting the
stereoselectivity. A variety of aromatic groups attached
to the N atom of the rhodanine, and to the N atom and
azomethinic carbon of the pyrazolones were permitted.
The 2’-thioxo-5,6-dihydrospiro[pyrano[2,3-c]pyrazole-
4,5’-thiazolidin]-4’-ones were obtained in high yields,
and excellent diastereomeric ratios and enantiomeric
excesses (Scheme 75).
5.2. Asymmetric Organocatalytic Reactions with
Oxazolidindione and Thiazolidindione Derivatives
In 2017, an asymmetric tandem conjugated addition/
protonation reaction of 3-substituted oxindoles and
1,3-oxazolidin-2,4-diones using a chiral bifunctional
urea/Brønsted base catalyst C48 was reported by
Jiang.[115] The reaction allowed to construct a quater-
nary and a secondary C  O stereogenic centers. The N-
Boc protecting group of the oxindole was required to
obtain good results. Methylene-1,3-oxazolidine-2,4-
diones having a phenyl, 4-Cl  , 4-MeO  or 3-F phenyl
groups attached to the N atom were successfully
employed. A variety of oxindoles having different
substitution at the aromatic ring, and benzyl or aryl
groups at position 3 reacted to give the corresponding
products with high to excellent yields, and excellent
diastereo- and enantioselectivities (Scheme 76).
Inspired by these results, the authors also studied
the addition of thiols using a related catalyst C49. In
this case, 5 Å molecular sieves and NaCl were needed
as additives (Scheme 77). A few thiols of different
nature (benzyl, aryl and alkyl) were studied, obtaining
high to excellent yields and enantioselectivities. The ee
of the reaction products could be increased above 99%
after crystallization.
Later, in 2019, Zhu and Chang employed azlactones
as nucleophiles for a similar asymmetric conjugate
addition/protonation reaction.[116] Again, a bifunctional
Scheme 73. Asymmetric formal [3+2] cycloaddition of N-
(2,2,2-trifluoroethyl)isatin ketimines and 5-arylidene-rhoda-
nines.
Scheme 74. Asymmetric cascade aza-Michael/Michael addition
reaction between rhodanine derivatives and β-(2-aminophenyl)
enones.
Scheme 75. Asymmetric [3+3] annulation between pyrazo-
lones and novel rhodanine ketoesters.
Scheme 76. Asymmetric addition of 3-substituted oxindoles to
methylene-1,3-oxazolidine-2,4-diones.
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urea/Brønsted base was used as catalyst. The ring size
linked to the tertiary amine of the catalyst played an
important role in the reaction, obtaining the best results
with an eight-membered ring C50. Different azlactones
and a wide variety of methylene 1,3-oxazolidine-2,4-
diones were studied obtaining in all cases the α-
diastereomer with excellent results. Moreover, when
2,2’-biphenol was used as additive and C51 as catalyst,
a diastereoselectivity switch was observed affording
the β diastereomer (Scheme 78).
Besides these conjugate addition reactions, Du and
Song described a formal [3+2] cycloaddition involv-
ing a cascade Michael/cyclization reaction of unsatu-
rated thiazolidinones and isothiocyanato oxindoles
catalyzed by bifunctional squaramide C52.[117] A
variety of N-protected 5-ylidene-thiazolidine-2,4-dio-
nes and isothiocyanato oxindoles were studied, afford-
ing oxindole-pyrrolidone-thiazolidinone bi-spirocyclic
heterocycles in high yields and excellent diastereo- and
enantioselectivities. The authors also tested a rhoda-
nine derivate as electrophile obtaining an excellent
yield (95%), good diastereoselectivity (88:12) and
moderate enantiomeric excess (62%) due to the lower
electronegativity of the substrate (Scheme 79).
5.3. Asymmetric Metal-Catalyzed Reactions with
Oxazolidindione and Thiazolidindione Derivatives
Despite the prevalence of organocatalytic procedures,
the first asymmetric reaction with 5-ylidene-thiazoli-
dine-2,4-diones was reported by Deng and Yu in 2015
using metal catalysis.[118] These compounds reacted as
dipolarophiles in the asymmetric 1,3-dipolar cyclo-
addition with azomethine ylides catalyzed by a chiral
copper complex with the chiral amino alcohol ligand
L5. The corresponding spirocyclic pyrrolidine-thiazoli-
dindione products containing a spiro-heteroquaternary
stereogenic center were obtained in good to excellent
yields, with excellent levels of diastereo- and enantio-
selectivity. Imines derived from aromatic or heteroar-
omatic aldehydes worked efficiently in the reaction.
Imines derived from 3-methylbutanal also were ad-
equate substrates, although the diastereomeric ratio
obtained in these cases was lower than with aromatic
imines. The thiazolidine-2,4-dione partner allowed
different aromatic or alkyl groups attached to the N
atom and the exocyclic double bond. The authors also
tested a few 5-ylidene-oxazolidine-2,4-diones (X=O)
bearing haloaromatic rings on the double bond that
reacted similarly to their sulfur analogues
(Scheme 80).
Scheme 77. Asymmetric addition of thiols to N-phenyl meth-
ylene-1,3-oxazolidine-2,4-dione.
Scheme 78. Asymmetric diastereodivergent addition of azlac-
tones to methylene-1,3-oxazolidine-2,4-diones.
Scheme 79. Asymmetric addition of 3-isothiocyanato oxindoles
to 5-arylidene-thiazolidine-2,4-diones.
Scheme 80. Asymmetric 1,3-dipolar cycloaddition of azome-
thine ylides and 5-ylidene-thiazolidine-2,4-diones.
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6. 4-Ylidene-Azlactones
Olefinic 2-oxazolones, so-called Erlenmeyer azlac-
tones, were synthesized in 1893 by Erlenmeyer
through a Perkin condensation of N-acetyl glycine with
acetic anhydride and sodium acetate.[119] These com-
pounds are very attractive in the synthesis of novel
heterocycles.[120] Furthermore, ring opening reactions
lead to the corresponding amino acid derivatives, for
example L-cyclohexylalanine[121] and L-
phenylalanine.[122] The phytotoxic tetrapeptide Tentoxin
can be also synthesized using an azlactone as starting
material.[123] Furthermore, the azlactone moiety itself
can be found in some biologically active compounds
including antibacterials and antifungals,[124] HCMV and
HSV-2 proteases inhibitors[125] and anti-inflammatory
agents.[126] Also, these heterocycles have been used as
titrant agents for the analysis of hydrolases[127] (Fig-
ure 6).
Condensation of azlactones with aldehydes gives 4-
ylidene-azlactones (Erlenmeyer-Ploch azlactones)
bearing an exocyclic double bond that can participate
as Michael acceptors or in cycloaddition reactions
generating spirocyclic compounds. Moreover, in ab-
sence of an external electrophile the Erlenmeyer-Ploch
azlactones can undergo a double nucleophilic attack
involving addition to the exocyclic double bond
followed by nucleophilic attack to the lactone carbonyl
in an inter- or intramolecular fashion with cleavage of
the azlactone ring. Cleavage of the azlactone ring is
favored by the formation of a stable amide gorup or
amide anion and is the driving force of many of the
reactions involving this kind of compounds. This
dielectrophilic behavior allows the synthesis of priv-
ileged amino acid derivatives with two continuous
stereocenters (Scheme 81). In general, Erlenmeyer-
Ploch azlactones are obtained as the more thermody-
namically stable Z isomers, although sometimes they
are obtained as a mixture of isomers that can be
separated by crystallization.
6.1. Organocatalytic Reactions with 4-Ylidene-
Azlactones
In the last years, organocatalytic asymmetric conjugate
additions to Erlenmeyer-Ploch azlactones have gained
relevance. Several protocols have been developed
using enamine, phosphine or phosphoric acid catalysis.
6.1.1. Reactions via Enamine Catalysis
As early as 2011, the group of Jørgensen described the
first asymmetric reaction involving 4-ylidene-azlac-
tones The authors developed an enamine-catalyzed
Diels-Alder reaction of 2,4-dienals with 4-ylidene-
azlactones (Scheme 82).[128] The reaction takes place
through a trienamine intermediate formed from the
dienal and the catalyst, and allows the synthesis of
rigid carbocyclic α,α-disubstituted amino acid deriva-
tives in a regio- and stereoselective way. To improve
the stability of the products and determine the
enantiomeric excesses, a homologation using a stabi-
lized phosphonium ylide (Wittig reaction) was done
achieving moderate yields and diastereoselectivities
and excellent enantiomeric excesses. The use of a
Ramirez olefination[129] (with PPh3=CBr2) instead of
the Wittig reaction improved both the yield and
diastereoselectivity. Apparently, the shorter reaction
time required for the Ramirez olefination reduced the
Figure 6. Selected compounds derived from Erlenmeyer azlac-
tones. Scheme 81. General reactivity of Erlenmeyer-Ploch azlactones.
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decomposition of the intermediate aldehyde, which
affected more the major diastereomer.
The results indicated that an aryl substituent on the
azlactone ring was vital for the reaction. Electron-
withdrawing and electron-donating as well as hetero-
aryl or even alkynyl substituents in the azlactone
exocyclic double bond were well tolerated affording
the desired products in moderated yields, good diaster-
eoselectivities and excellent enantiomeric ratios. The
authors propose that regioselectivity is determined by
maximized orbital overlap between the HOMO of C6
of the aldehyde and C3’ in the ylidene-azlactone. Endo
selectivity was favored by secondary orbital interac-
tions including possible π-π interactions (Scheme 82).
6.1.2. Bifunctional Hydrogen-Bonding/Brønsted Base
Catalysis
Bifunctional catalysts have been widely applied in
enantioselective reactions with 4-arylidene-azlactones.
In 2012, Wang and co-workers developed an organo-
catalytic cascade thia-Michael/ring opening reaction
between arylthiols and 4-arylidene-azlactones.[130] The
corresponding β-thio-α-amino acids resulting from
thia-Michael addition and thiolysis of the azlactone
were obtained with excellent yields and diastereoselec-
tivities and good enantiomeric excesses using Take-
moto thiourea C28 as catalyst. Electron-donor and
electron-withdrawing substituents at the exocyclic
double bond of the 4-arylidene-azlactones were suited.
Substituted arylthiols reacted similarly regardless of
the characteristics of the substituent (Scheme 83).
One year later, an organocatalytic Michael/cycliza-
tion reaction between 3-isothiocyanato oxindoles and
4-arylidene-azlactones was studied by Yuan.[131] A
quinine thiocarbamate C53 catalyzed the formal [3+
2] cycloaddition to give bi-spirocyclic thiopyrrolidine-
oxindoles in excellent yields and stereoselectivities. A
broad variety of 4-arylidene-azlactones containing
electron-withdrawing, electron-donating, bulky aryl or
heteroaryl substituents in R1 or R2 were tolerated
giving in all cases excellent results. Some 3-isothio-
cyanato oxindoles were also studied obtaining the best
result with N-Me protected ones (Scheme 84).
In 2014, Xu developed a cascade [3+2] cyclo-
addition/transesterification reaction between o-salicy-
laldehyde imines and 4-ylidene-azlactones catalyzed
by thiourea C25.[132] A good number of 4-ylidene-
azlactones bearing aryl, heteroaryl or cyclohexyl
groups were studied obtaining the corresponding
polysubstituted chromeno[4,3-b]pyrrolidines with ex-
cellent yields and stereoselectivities. Imines of sub-
stituted salicylic aldehydes were also suitable sub-
strates for the reaction (Scheme 85). Remarkably, a
gram scale reaction was performed giving the desired
product with excellent results.
Recently, Du studied the organocatalytic asymmet-
ric formal [3+2] cycloaddition involving a domino
Michael/Mannich process of N-(2,2,2-trifluoroethyl)
Scheme 82. Trienamine catalysis in the Diels-Alder reaction of
2,4-dienals and 4-ylidene-azlactones.
Scheme 83. Cascade thia-Michael/ring opening between arylth-
iols and 4-arylidene-azlactones.
Scheme 84. Organocatalytic Michael/cyclization reaction be-
tween 3-isothiocyanato oxindoles and 4-ylidene-azlactones.
Scheme 85. Cascade [3+2] cycloaddition/transesterification
between o-salicylaldehyde imines and 4-ylidene-azlactones.
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isatin ketimines and 4-arylidene-azlactones catalyzed
by a dihydroquinine-derived thiourea C54.[133] Due to
the instability of the resulting tricyclic products, a one
pot hydrolysis was carried out to obtain the corre-
sponding 3,2’-pyrrolidinyl spirooxindoles bearing four
vicinal stereogenic centers. A variety of isatin keti-
mines were studied obtaining excellent results regard-
less of the electronic characteristics of the substituents
on the aromatic ring. 4-Arylidene-azlactones were also
evaluated founding that electron-withdrawing and
electron-donating groups in R1 and R2 were well
tolerated, although when R1 was an heteroaryl or bulky
aryl group lower yields and enantiomeric excesses
were obtained (Scheme 86).
Nazarov reagents (γ,δ-unsaturated β-ketoesters) can
react with Erlenmeyer-Ploch azlactones to synthesize
highly functionalized spirocycles. Thus, in 2014, a
double Michael addition between Nazarov reagents
and 4-arylidene-azlactones catalyzed by a bifunctional
thiourea-tertiary amine C55 was described by Yuan
(Scheme 87).[134]
4Å Molecular sieves was needed to improve the
chemical yield. tert-Butyl Nazarov esters gave better
results than ethyl esters and electron-poor or p-Me
substituted aryl rings in R3 produced a decrease in
yield and enantiomeric excess. Conversely, different 4-
arylidene-azlactones were suitable substrates independ-
ently of the electronic characteristics of the substitu-
ents on the aryl ring (Scheme 87).
In 2016, Zhou reported what they described as an
asymmetric [3+3] annulation between indolin-2-thio-
nes and 4-benzylidene-azlactones.[135] The reaction,
catalyzed by the chiral squaramide C56, proceeded via
a tandem Michael addition/thiolactonization process.
Cyclic tryptophan derivatives were prepared in accept-
able yields and excellent diastereoselectivities for
several 4-benzylidene-azlactones bearing electron-do-
nating or electron-withdrawing substituents in R1 and a
number of substituted N-methylindolin-2-thiones
(Scheme 88).
Like indolin-2-thiones, cyclohexane-1,3-diones can
also participate in formal [3+3] cycloadditions with 4-
ylidene-azlactones as Shi and Tu reported in 2016.[136]
The reaction was catalyzed by the chiral thiourea C57
affording structurally diverse 3-aminohexahydrocou-
marin derivatives with high stereoselectivity. The
addition of 5Å molecular sieves was needed to avoid
hydrolysis of the azlactone and improve the chemical
yield. A broad variety of 4-ylidene-azlactones having
aromatic or heteroaromatic groups attached to the
exocyclic double bond or to the azomethinic carbon
reacted with 5,5-dimethylcyclohexane-1,3-dione to
give the expected products with fair to good yields,
excellent diastereoselectivities and fair to good enan-
tioselectivities. 4-Ylidene-azlactones bearing an ali-
phatic group at either position did not react. Cyclo-
heptane-1,3-dione was also reactive, while
cyclopentane-1,3-dione did not react and acyclic
pentane-2,4-dione required higher temperature and
provided an almost racemic product, but with high
diastereoselectivity (Scheme 89).
Scheme 86. Domino Michael/Mannich cycloaddition of isatin
ketimines and 4-arylidene-azlactones.
Scheme 87. Double Michael addition with ketoesters and 4-
arylidene-azlactones.
Scheme 88. Asymmetric [3+3] cycloaddition between indolin-
2-thiones and 4-benzylidene-azlactones.
Scheme 89. Organocatalytic [3+3] cycloaddition of diketones
and 4-ylidene-azlactones.
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6.1.3. Phosphine Catalysis
In 2012, Jørgensen and co-workers developed a [3+2]
cycloaddition between allenoates and 4-arylidene-
azlactones catalyzed by (S)-BINEPHINE
(Scheme 90).[137] The reaction was performed under a
temperature gradient from room temperature to 80 °C
to give the γ-addition product as the major isomer (γ/
α=5:1) with high enantiomeric excess (93%ee).
The authors then envisioned a one-pot [3+2]
cycloaddition/methanolysis procedure directly access-
ing N-protected amino acid derivatives with a variety
of 4-arylidene-azlactones. The reaction crude was
treated with MeOH/TMSCl and the γ-addition-derived
aminoacids were isolated as the major products in
moderate yields and regioselectivities, but excellent
enantiomeric excesses (Scheme 91).
A modification of the phosphine catalyst and
reaction conditions allowed Shi to perform the same
reaction with almost full regioselectivity favoring the
γ-isomer.[138] By using the chiral phosphine C59 in the
presence of 4Å molecular sieves the corresponding
spiro compounds were obtained in good to high yields
and excellent stereoselectivities for a number of differ-
ent 4-ylidene-azlactones regardless of the electronic
character of the substituent in R1. Heteroaryl and
aliphatic substituents were also well tolerated. Benzyl
and alkyl allenoates reacted properly with similar
results (Scheme 92).
Remarkably, the phosphine-catalyzed reaction of
allenoate esters with arylidene-azlactones leads to the
[3+2] cycloaddition product in contrast with the [4+
2] product obtained with arylidene-dioxopyrrolidines
(see Scheme 61), which indicates the different charac-
ter of the carbonyl group in both heterocycles.
6.1.4. Phosphoric Acid Catalysis
In 2016, Takemoto and co-workers developed a
tandem aza-Michael/ring opening reaction between N-
Boc hydroxylamine and 4-ethylidene-azlactones cata-
lyzed by a phosphoric acid C60.[139] The authors found
that the use of catalysts bearing a tertiary amine, i. e.
bifunctional thiourea/amine catalysts, promoted the
undesired O-1,2-addition with cleavage of the azlac-
tone ring owing to activation of the more acidic OH
group of the hydroxylamine by the tertiary amine. The
aza-Michael products obtained upon acid catalysis
with C60 were unstable and therefore transformed into
diamino esters by methanolysis. The authors found that
the E and Z isomers of the azlactone provided opposite
enantiomers, with the E isomer reacting faster and with
higher enantioselectivity. Initially the E isomer was
chosen as starting material and, since both diastereom-
ers equilibrate in solution, conditions were set to
minimize the reaction of the formed Z-isomer. The
diamino compounds were obtained in moderate yields
and diastereoselectivities but high enantiomeric ex-
cesses for a few examples of aryl substituted (E)-
azlactones (Scheme 93).
Scheme 90. [3+2] Cycloaddition between allenoates and 4-
arylidene-azlactones.
Scheme 91. One pot [3+2] cycloaddition/methanolysis be-
tween allenoates and 4-arylidene-azlactones.
Scheme 92. [3+2] Cycloaddition between allenoates and 4-
arylidene-azlactones.
Scheme 93. Tandem aza-Michael/ring opening reaction be-
tween N-Boc hydroxylamine and (E)-azlactones.
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Due to the difficulty to prepare the (E)-azlactones,
a method for the in situ isomerization of (Z)-azlactones
was developed. For this purpose, triphenylphosphine
was used as co-catalyst to promote isomerization of
the ylidene-azlactone. In this way, the anti-α,β-
diaminoacids were obtained with similar or slightly
higher yields, similar diastereoselectivity but lower
enantiomeric excesses than when starting from the E
isomer (Scheme 94).
6.2. Metal-Catalyzed Reactions
In 2011, Trost and Morris developed a formal [3+2]
cycloaddition of vinyl cyclopropanes with 4-ylidene-
azlactones catalyzed by a palladium complex with
chiral ligand L6 (Scheme 95).[140]
The reaction involves the participation of a π-allyl
Pd-complex dipole formed from the vinylcyclopropane
diester. Trifluoroethyl esters were used in this case to
stabilize the dipole intermediate. The synthesis of
spirocyclopentane-azlactones was achieved in moder-
ate yield and excellent stereoselectivity with different
4-arylidene-azlactones bearing meta- and para- sub-
stituted phenyl rings attached to the double bond, while
4-alkylidene- azlactones provided the corresponding
spiro compounds in lower yield and stereoselectivity
(Scheme 95).
In 2013, Carretero and Adrio described the 1,3-
dipolar cycloaddition of azomethine ylides and 4-
ylidene-azlactones catalyzed by a silver/DTBM-Seg-
phos (L7) complex.[141] Due to the instability of the
resulting spirocyclic pyrrolidines, a one-pot methanol-
ysis was carried out obtaining the corresponding
pyrrolidine dicarboxylate derivatives. A broad variety
of aromatic azomethine ylides were studied obtaining
good to moderate yields and excellent stereoselectiv-
ities. Unfortunately, the cyclohexyl-substituted ylide
did not react under the optimized conditions. Azlac-
tones substituted at the double bond with phenyl
groups bearing either electron-withdrawing or elec-
tron-donating groups or with heteroaromatic rings
were well tolerated. Alkenyl azlactones gave moderate
yields and excellent enantioselectivities (Scheme 96).
7. 5-Ylidene-Thiazolones
Thiazoles are five-membered heterocycles containing
nitrogen and sulfur atoms that can be found in a broad
variety of biologically active compounds.[142] Further-
more, thiazoles are privileged scaffolds in drug
discovery.[143] Some examples include anti-HIV-
drugs,[144] insecticides,[145] antiparasitic,[146] antiulcer,[147]
and antineoplastic agents.[148] Otherwise, the thiazol-4-
one moiety plays a crucial role in the synthesis of
bioactive compounds too. Antiobesity,[149]
antimicrobial[150] and antiviral[151] agents are some of
the examples containing this scaffold (Figure 7).
Scheme 94. Tandem isomerization/aza-Michael/ring opening
reaction between N-Boc hydroxylamine and (Z)-azlactones.
Scheme 95. Formal [3+2]-cycloaddition of vinyl cyclopro-
panes with 4-ylidene-azlactones.
Scheme 96. 1,3-Dipolar cycloaddition of azomethine ylides and
4-ylidene-azlactones.
Figure 7. Selected bioactive compounds containing the thiazole
and thiazol-4-one moieties.
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7.1. Organocatalytic Reactions with 5-Ylidene-Thia-
zolones
5-Ylidene-thiazolones[152] have been used in a broad
variety of organocatalytic asymmetric reactions due to
their versatility. Chiral branched thiazoles can be
synthesized by Michael addition, and fused thiazoles
can be obtained through cascade Michael/oxa-cyclo-
addition reactions. Moreover, spirocompounds contain-
ing the thiazolone moiety can be obtained through
Michael/cyclization reactions (Scheme 97).
7.1.1. Reactions via NHC Catalysis
N-heterocyclic carbene catalysis was used in the first
enantioselective reaction employing 5-arylidene-thia-
zol-4-ones as substrates. In 2015, Wang developed an
oxidative annulation of aldehydes and 5-arylidene-
thiazol-4-ones to afford functionalized chiral thiazolo-
pyrones.[153] The N-heterocyclic carbene C7 was used
as catalyst together with a stoichiometric amount of
3,3’,5,5’-(tBu)4-diphenoquinone (O) as oxidant. Also,
an inorganic base was required to form the aldehyde
enolate, NaOAc being the optimal choice. A number
of 5-arylidene-thiazol-4-ones bearing differently sub-
stituted phenyl or heteroaromatic rings attached to the
double bond reacted with butanal and other aliphatic
aldehydes to give the reaction products in high yields
and excellent diastereo- and enantioselectivities
(Scheme 98).
A modification of the reaction conditions was
developed to permit the use of a catalytic amount of
3,3’,5,5’-(tBu)4-diphenoquinone (O) and molecular
oxygen as terminal oxidant. In this case, the combina-
tion of NHC C61 and Et3N as the base provided the
best results (Scheme 99).
On the other hand, α-chloroaldehydes were used by
Enders in a [4+2] annulation with 5-arylidene-thiazol-
4-ones to give the same compounds under non-
oxidative conditions (Scheme 100).[154]
In this reaction, NHC C62 and NaOAc were chosen
as the optimal catalyst and base, respectively. Several
α-chloroaldehydes reacted with 5-arylidene-thiazol-4-
ones bearing electron-donating and electron-withdraw-
ing groups, affording the products in excellent yields
and stereoselectivities regardless of the substitution
pattern (Scheme 100).
In 2016, Ye developed an asymmetric synthesis of
thiazole-fused ɛ-lactones through an NHC-catalyzed [3
+4] cycloaddition of enals and 5-arylidene-thiazol-4-
ones.[155] The reaction occurs through a homoenolate
equivalent formed from the enal and the catalyst
without oxidation. The base played an important role
in the reaction, as the use of cesium carbonate or DBU
instead of KOAc decreased the yield because of
formation of the competitive [3+2] cycloadduct as
side product. A broad variety of 5-arylidene-thiazol-4-
ones having aromatic rings of different electronic
nature reacted with enals substituted with short and
long alkyl groups to give exclusively the cis product
with good yields and enantioselectivities. Cinnamalde-
hyde derivatives also worked in this reaction, although
in this case the diastereoselectivity was lower, still
favoring the cis isomer (Scheme 101).
Scheme 97. General reactivity of 5-ylidiene-thiazolones.
Scheme 98. Oxidative annulation of aldehydes and 5-arylidene-
thiazol-4-ones.
Scheme 99. Oxidative annulation of aldehydes and 5-arylidene-
thiazol-4-ones with oxygen as terminal oxidant.
Scheme 100. [4+2] Annulation of α-chloroaldehydes and 5-
arylidene-thiazol-4-ones.
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7.1.2. Brønsted Base and Bifunctional Hydrogen-
Bonding/Brønsted Base Catalysis
Bifunctional hydrogen-bonding/Brønsted base catalysis
was used in 2016 by Zhou in an asymmetric formal [2
+4] cycloaddition of malononitrile and 5-ylidene-
thiazol-4-ones.[156] The reaction was catalyzed by a
chiral squaramide C64 derived from L-tert-leucine and
led to 7H-pyrano[2,3-d]thiazole derivatives via a
Michael addition/alkoxide addition to nitrile. The yield
and enantioselectivity of the reaction were highly
influenced by the substituents R1 and R2 (Scheme 102).
In 2019, an organocatalytic [3+2] cycloaddition
between CF3-containing azomethine ylides and 5-
arylidene-thiazol-4-ones was described by Yan and
Wang.[157] Rigid chiral tertiary amine β-isocupreidine
catalyst C65 gave the desired CF3-containing spiro-
thiazolone-pyrrolidines (Scheme 103).
A wide range of 2-phenylthiazolones having sub-
stituted phenyl rings with either electron-withdrawing
or electron-donating groups at different positions
reacted to give the expected products with good yields
and excellent enantioselectivities. The aryl group
attached to the azomethinic carbon was also amenable
to variation permitting substituents of different elec-
tronic character.
In 2020, Li, Peng and Jiang studied another organo-
catalytic formal 1,3-dipolar cycloaddition between N-
(2,2,2-trifluoroethyl)isatin ketimines and 5-ylidene-
thiazol-4-ones to obtain pyrrolidinyl spirooxindoles.[158]
The best results were obtained with the basic catalyst
(DHQD)2PYR C66. The reaction supported a variety
of 5-arylidene-thiazol-4-ones having aromatic or heter-
oaromatic rings of different substitution and electronic
character at R1 and R2, as well as substituents on the
aromatic ring and N1 of the isatin derivative
(Scheme 104). The reaction products were obtained in
good yields as only one diastereomer (α) with high
enantiomeric excesses. It is worth mentioning that
when the reaction was carried out in the presence of
squaramide C67 the epimer at one of the spiranic
carbons was obtained as the major diastereomer (β),
albeit almost racemic (see Scheme 105).
Moreover, the authors found that, upon acidic
treatment, the enantioenriched α diastereomer or the
racemic β diastereomer could be isomerized to another
diastereomer (γ) via a cascade ring-opening/retro-
Mannich reaction followed by a carbon-carbon bond-
reforming event driven by thermodynamic preferences.
Notably, when starting from enantioenriched α this
transformation occurred without loss of the enantio-
meric excess (Scheme 105).
An organocatalytic formal [2+1] Michael addition/
alkylation reaction between 3-chlorooxindoles and 5-
arylidene-thiazol-4-ones catalyzed by Takemoto thiour-
ea C28 was reported by Sheng in 2019 to give bi-
spirocyclic oxindoles containing a cyclopropane ring
and three stereogenic centers.[159] The stereoselectivity
of the reaction showed a notable dependence on the
base and the solvent employed, selecting Et3N and
Scheme 101. [3+4]-Cycloaddition of enals with 5-arylidene-
thiazol-4-ones.
Scheme 102. Formal [2+4] cycloaddition of malononitriles
with 5-ylidene-thiazol-4-ones.
Scheme 103. Formal [3+2]-cycloaddition between CF3-con-
taining azomethine ylides and 5-arylidene-thiazol-4-ones.
Scheme 104. Formal 1,3-dipolar cycloaddition between N-
(2,2,2-trifluoroethyl)isatin ketimines and 5-ylidene-thiazol-4-
ones.
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EtOAc as the best candidates. Aromatic 3-chloroox-
indoles were tested obtaining the best results with C5
and C6 substituted ones, regardless of the electronic
features of the substituents. Different substitution in R1
or R2 of the 5-arylidene-thiazol-4-ones was possible.
The reaction products were obtained with fair to good
yields and diastereoselectivities and high enantiomeric
excesses (Scheme 106).
The same reaction was reported by Du using the
quinine-derived squaramide C26 as catalyst and
Na2CO3 as base in acetonitrile at   10 °C.[160] These
conditions provided the reaction products in higher
yield, and better diastereoselectivity and enantioselec-
tivity than those reported by Sheng. Regarding the
reaction scope, C6-substituted 3-chlorooxindoles gave
the best results. Moreover, N-benzyl substituted 3-
chlorooxindoles were suited. In addition, some 5-
arylidene-thiazol-4-ones were studied, observing that
electronic changes in R1 only affected slightly the
chemical yield. Electron-poor, electron-rich, heteroaryl
and bulkier substituents in R2 gave excellent results
(Scheme 107).
A single Michael addition of pyrazolones to 5-
ylidene-thiazol-4-ones using the bifunctional squara-
mide C17 as catalyst was described in 2018 by
Shen.[161] Due to the high polarity of the products an
acylation step was required to facilitate the purification
process. 5-Arylidene-thiazol-4-ones were evaluated,
founding that methyl and halogenated substitution in
meta- and ortho- positions gave the best results.
Disubstituted or bulky aryl rings in R1 were also
studied obtaining the desired products in high yields
and excellent enantiomeric excesses. Unfortunately, 5-
alkylidene-thiazol-4-ones (R1=alkyl) were not suitable
substrates (Scheme 108).
Du developed a synthesis of 4-acyloxythiazole
derivatives through an asymmetric cascade Michael
addition/hemiketalization/retro-aldol reaction between
α-nitroketones and 5-arylidene-thiazol-4-ones cata-
lyzed by the bifunctional squaramide C17
(Scheme 109).[162]
A variety of aromatic and heteroaromatic groups at
R1 and R2 were tolerated. Furthermore, different aryl,
heteroaryl and methyl groups attached to the carbonyl
group of the nitroketones were possible and did not
affect seriously the yield and stereoselectivity of the
reaction (Scheme 109).
7.1.3. Phosphine and Phosphonium Salt Catalyzed
Reactions
The first example of a phosphine-catalyzed reaction
involving 5-arylidene-thiazol-4-ones appeared in
Scheme 105. Isomerization of spirocyclic oxindoles.
Scheme 106. Synthesis of fused spirooxindole-spirothiazolones
described by Sheng.
Scheme 107. Synthesis of fused spirooxindole- spirothiazolones
described by Du.
Scheme 108.Michael addition of pyrazolones to 5-ylidene-
thiazol-4-ones.
Scheme 109. Cascade Michael/hemiketalization/retro-aldol re-
action between α-nitroketones and 5-arylidene-thiazol-4-ones.
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2016.[163] In this report by Xiao, a [2+4] annulation of
allenoates with 5-arylidene-thiazol-4-ones to give 6,7-
dihydro-5H-pyrano[2,3-d]thiazoles was described.
First, the authors developed the racemic version of this
reaction, using PMe2Ph as catalyst obtaining moderate
to high yields. Motivated by these results, the
enantioselective version of the reaction was studied
founding Kwon phosphine C68 as the best catalyst.
Only four examples were studied of the asymmetric
version, obtaining in all cases high yields and excellent
enantioselectivities. Unfortunately, the absolute config-
uration of the reaction products could not be deter-
mined (Scheme 110).
In 2020, the group of Wang studied the formal [2+
4] annulation between 5-arylidene-thiazol-4-ones and
o-hydroxyphenyl substituted p-quinone methides cata-
lyzed by a bifunctional phosphonium salt C69.[164]
Spiro[chroman-thiazolones] were synthesized in excel-
lent yield and stereoselectivity from 5-arylidene-
thiazol-4-ones bearing para-substituted rings with
either electron-withdrawing or electron-donating
groups in R1. Unfortunately, ortho-substitution gave
lower enantiomeric excesses. Heteroaryl and bulkier
substituents as naphthyl in the 5-arylidene-thiazol-4-
ones were well tolerated. Furthermore, a number of o-
hydroxyphenyl substituted p-quinone methides was
tested, obtaining excellent results in all cases
(Scheme 111).
7.1.4. Reactions via Enamine Catalysis
Enamine catalysis is also present in enantioselective
reactions involving 5-arylidene-thiazol-4-ones. In
2018, Li et al. developed a formal oxa-Diels-Alder
reaction between aliphatic aldehydes and 5-arylidene-
thiazol-4-ones catalyzed by the Hayashi-Jørgensen
catalyst (C1).[165] The use of benzoic acid and aqueous
solvent was required to increase the yield of the
reaction. The initial hemiacetals were reduced with
Et3SiH to give thiazole-fused dihydropyran derivatives
as a single diastereomer. Aliphatic aldehydes and
phenylpropanal reacted with 5-arylidene-thiazol-4-ones
containing aromatic groups of different electronic
nature and substitution to give the reaction products in
high yields and enantioselectivities (Scheme 112).
Moreover, this methodology was extended to the
use of more challenging aqueous acetaldehyde. The
bicyclic heterocycles were obtained in outstanding
yields with good diastereoselectivity and excellent
enantioselectivity (Scheme 113).
7.1.5. Isothiourea-Catalyzed Reactions
As mentioned above, Pericàs developed an immobi-
lized isothiourea catalyst that was used in the formal
[4+2] cycloaddition of arylacetic acids and different
ylidene-heterocycles such as 4-ylidene-pyrazolones
(Scheme 34).[48] As a part of this work, the reaction of
5-benzylidene-2-phenylthiazol-4(5H)-one with several
arylacetic acids was also studied obtaining in all cases
Scheme 110. [2+4] Annulation of allenoates with 5-arylidene-
thiazol-4-ones.
Scheme 111. Formal [2+4] annulation of o-hydroxyphenyl-
substituted p-quinone methides with 5-arylidene-thiazol-4-ones.
Scheme 112. Formal oxa-Diels-Alder reaction between aliphatic
aldehydes and 5-arylidene-thiazol-4-ones.
Scheme 113. Formal oxa-Diels-Alder reaction between aqueous
acetaldehyde and 5-arylidene-thiazol-4-ones.
Scheme 114. Formal [4+2] cycloaddition of arylacetic acids
and 5-arylidene-thiazol-4-ones.
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the reaction product as a single stereoisomer
(Scheme 114).
8. Conclusion
The ylidene-five-membered heterocycles reviewed in
this article have shown an enormous potential as
substrates in asymmetric catalysis for the synthesis of
a vast diversity of chiral heterocyclic compounds.
Simple conjugate addition to the exocyclic bond, many
times favored by aromatization, have permitted the
preparation of aromatic heterocycles decorated with
chiral pendant chains. These compounds have also
shown the ability of the exocyclic double bond to
participate as dienophile or dipolarophile in formal
cycloaddition reactions leading to spirocyclic com-
pounds. On the other hand, the presence of an
unsaturated carbonyl group permits this kind of
compounds to participate in a number of formal
cycloadditions leading to bi- or poly- cyclic fused
heterocycles by reacting as heterodienes in [4+n]
cycloadditions or as bis-electrophiles. Furthermore, the
presence of two electrophilic sites, the exocyclic
double bond and the heterocyclic carbonyl group,
confers a bis-electrophilic character that has been
profited in the synthesis of fused heterocycles by
reacting with reaction partners with bis-nucleophilic
character. These reactions have been made possible in
an enantioselective fashion with different catalysts,
especially organocatalysts, that operate by different
activation modes. Bifunctional hydrogen-bonding/
Brønsted base and enamine catalysis have resulted
especially powerful, but other catalysis; i. e. nucleo-
philic phosphine, phosphoric Brønsted acid or NHC
catalysis; have been also efficient depending on the
reaction partner. Besides, some metal-catalyzed reac-
tions have been described. Despite these results,
reactions involving single conjugate additions have
been little explored. Studies addressed to developing
new conjugate addition reactions of new nucleophiles
are foreseen. Furthermore, given the rich chemistry of
these compounds, further development will involve
new reaction patterns in cycloaddition reactions with
new substrates through different activation modes.
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